Gclc | Rat | (+)-catechin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Oxygen deficiency co-treated with Catechin] results in increased expression of GCLC mRNA | CTD | PMID:35883890 |
Gclc | Rat | (+)-schisandrin B | increases activity | EXP | | 6480464 | schizandrin B analog results in increased activity of GCLC protein | CTD | PMID:21328628 |
Gclc | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GCLC mRNA] | CTD | PMID:31150632 |
Gclc | Rat | (+/-)-Aegeline | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GCLC mRNA | CTD | PMID:28843594 |
Gclc | Rat | (-)-epigallocatechin 3-gallate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | epigallocatechin gallate results in increased expression of GCLC mRNA | CTD | PMID:25585349 |
Gclc | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [arsenite co-treated with epigallocatechin gallate] results in increased expression of GCLC protein | CTD | PMID:29572906 |
Gclc | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of GCLC mRNA | CTD | PMID:36331819 |
Gclc | Rat | (2,4,5-trichlorophenoxy)acetic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:16426233 |
Gclc | Rat | (2,4,5-trichlorophenoxy)acetic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:10377250 and PMID:16426233 |
Gclc | Rat | (E)-cinnamyl alcohol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | (R)-lipoic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Thioctic Acid results in increased expression of GCLC mRNA | CTD | PMID:16249512 more ... |
Gclc | Rat | (R)-lipoic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Thioctic Acid promotes the reaction [Cadmium Chloride results in increased expression of GCLC mRNA] and Thioctic Acid results in increased expression of and results in increased activity of GCLC protein | CTD | PMID:26365678 |
Gclc | Rat | (R)-lipoic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Thioctic Acid inhibits the reaction [Silicon results in decreased expression of GCLC protein] | CTD | PMID:34252510 |
Gclc | Rat | (R)-lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [methylmercuric chloride results in decreased expression of GCLC protein] more ... | CTD | PMID:27298056 and PMID:32061141 |
Gclc | Rat | (R,R,R)-alpha-tocopherol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLC mRNA | CTD | PMID:24530478 |
Gclc | Rat | (RS)-coclaurine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GCLC mRNA | CTD | PMID:28843594 |
Gclc | Rat | (RS)-norcoclaurine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GCLC mRNA | CTD | PMID:28843594 |
Gclc | Rat | (S)-coclaurine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GCLC mRNA | CTD | PMID:28843594 |
Gclc | Rat | (S)-colchicine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Colchicine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA] | CTD | PMID:37573684 |
Gclc | Rat | (S)-naringenin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [naringenin results in increased expression of GCLC protein] | CTD | PMID:31254498 |
Gclc | Rat | (S)-naringenin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | naringenin results in increased expression of GCLC protein | CTD | PMID:31254498 |
Gclc | Rat | (S)-nicotine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 |
Gclc | Rat | 1,1'-azobis(N,N-dimethylformamide) | increases activity | EXP | | 6480464 | Diamide results in increased activity of GCLC protein | CTD | PMID:15115889 |
Gclc | Rat | 1,1'-azobis(N,N-dimethylformamide) | increases expression | EXP | | 6480464 | Diamide results in increased expression of GCLC mRNA and Diamide results in increased expression of GCLC protein | CTD | PMID:15115889 |
Gclc | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | affects expression | EXP | | 6480464 | o and p'-DDT affects the expression of GCLC mRNA | CTD | PMID:17984292 |
Gclc | Rat | 1,2-dichloroethane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [ethylene dichloride co-treated with Ethanol] results in increased expression of GCLC mRNA more ... | CTD | PMID:30664321 and PMID:37150348 |
Gclc | Rat | 1,2-dichloroethane | increases expression | ISO | Gclc (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of GCLC protein | CTD | PMID:37150348 |
Gclc | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of GCLC mRNA | CTD | PMID:22206623 |
Gclc | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GCLC mRNA | CTD | PMID:22206623 |
Gclc | Rat | 1,3-benzothiazole-2-thiol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | captax results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
Gclc | Rat | 1,3-dichloropropan-2-ol | increases expression | EXP | | 6480464 | 1 and 3-dichloro-2-propanol results in increased expression of GCLC mRNA | CTD | PMID:26143167 |
Gclc | Rat | 1-bromopropane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 promotes the reaction [1-bromopropane results in increased expression of GCLC mRNA] | CTD | PMID:20211940 |
Gclc | Rat | 1-bromopropane | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 1-bromopropane results in increased expression of GCLC mRNA | CTD | PMID:20211940 |
Gclc | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased expression of GCLC mRNA | CTD | PMID:20146380 and PMID:20566472 |
Gclc | Rat | 1-fluoro-2,4-dinitrobenzene | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Dinitrofluorobenzene results in increased expression of GCLC mRNA | CTD | PMID:23999411 |
Gclc | Rat | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 |
Gclc | Rat | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 |
Gclc | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of GCLC mRNA | CTD | PMID:20551477 |
Gclc | Rat | 1-naphthyl isothiocyanate | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of GCLC mRNA | CTD | PMID:37348807 |
Gclc | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of GCLC protein and tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of GCLC mRNA] | CTD | PMID:37348807 |
Gclc | Rat | 15-deoxy-Delta(12,14)-prostaglandin J2 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 15-deoxy-delta(12 more ... | CTD | PMID:21728338 |
Gclc | Rat | 15-deoxy-Delta(12,14)-prostaglandin J2 | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 15-deoxy-delta(12 more ... | CTD | PMID:21728338 |
Gclc | Rat | 17alpha-ethynylestradiol | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Ethinyl Estradiol affects the expression of GCLC mRNA | CTD | PMID:20170705 and PMID:26865667 |
Gclc | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GCLC mRNA | CTD | PMID:26496021 |
Gclc | Rat | 17beta-estradiol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Estradiol results in increased expression of GCLC mRNA | CTD | PMID:39298647 |
Gclc | Rat | 17beta-estradiol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of GCLC mRNA | CTD | PMID:30165855 |
Gclc | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of GCLC mRNA and Estradiol results in increased expression of GCLC protein | CTD | PMID:31119341 and PMID:32145629 |
Gclc | Rat | 1H-pyrazole | increases expression | ISO | Gclc (Mus musculus) | 6480464 | pyrazole results in increased expression of GCLC mRNA | CTD | PMID:17945193 |
Gclc | Rat | 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 2' more ... | CTD | PMID:31029725 |
Gclc | Rat | 2',4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [2' more ... | CTD | PMID:31029725 |
Gclc | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:25659769 |
Gclc | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Eicosapentaenoic Acid analog co-treated with Docosahexaenoic Acids analog] promotes the reaction [2 more ... | CTD | PMID:25659769 |
Gclc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of GCLC mRNA more ... | CTD | PMID:16054899 more ... |
Gclc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of GCLC mRNA | CTD | PMID:29704546 |
Gclc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCLC mRNA | CTD | PMID:20702594 more ... |
Gclc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:15328365 more ... |
Gclc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCLC mRNA | CTD | PMID:21215274 more ... |
Gclc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:19542225 and PMID:21802500 |
Gclc | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:16960034 |
Gclc | Rat | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | ISO | Gclc (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:20702594 |
Gclc | Rat | 2,4,6-trinitrobenzenesulfonic acid | multiple interactions | EXP | | 6480464 | [Trinitrobenzenesulfonic Acid co-treated with Ethanol] results in increased expression of GCLC mRNA | CTD | PMID:10830784 |
Gclc | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Gclc (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 |
Gclc | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of GCLC mRNA | CTD | PMID:21346803 |
Gclc | Rat | 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Butylated Hydroxytoluene results in increased expression of GCLC protein | CTD | PMID:21536018 |
Gclc | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of GCLC mRNA | CTD | PMID:21346803 |
Gclc | Rat | 2-(chloromethyl)pyridine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-chloromethylpyridine results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | 2-acetamidofluorene | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-Acetylaminofluorene results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
Gclc | Rat | 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLC mRNA and [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GCLC mRNA | CTD | PMID:14656948 and PMID:16158176 |
Gclc | Rat | 2-acetamidofluorene | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 2-Acetylaminofluorene results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
Gclc | Rat | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 8-oxoberberine promotes the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of GCLC mRNA] more ... | CTD | PMID:35691465 |
Gclc | Rat | 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Glucosamine analog results in increased expression of GCLC mRNA | CTD | PMID:21825963 |
Gclc | Rat | 2-butoxyethanol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of GCLC mRNA | CTD | PMID:19812364 |
Gclc | Rat | 2-chloroethanol | increases expression | EXP | | 6480464 | Ethylene Chlorohydrin results in increased expression of GCLC mRNA and Ethylene Chlorohydrin results in increased expression of GCLC protein | CTD | PMID:31585129 |
Gclc | Rat | 2-chloroethanol | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of GCLC mRNA] more ... | CTD | PMID:31585129 |
Gclc | Rat | 2-hydroxyethyl methacrylate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | hydroxyethyl methacrylate results in increased expression of GCLC mRNA and hydroxyethyl methacrylate results in increased expression of GCLC protein | CTD | PMID:30497689 |
Gclc | Rat | 2-hydroxypropanoic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | 2-nitrofluorene | increases expression | EXP | | 6480464 | 2-nitrofluorene results in increased expression of GCLC mRNA | CTD | PMID:14600272 and PMID:15890375 |
Gclc | Rat | 2-tert-butylhydroquinone | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of GCLC mRNA] more ... | CTD | PMID:19328227 more ... |
Gclc | Rat | 2-tert-butylhydroquinone | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in decreased expression of GCLC mRNA | CTD | PMID:35724838 |
Gclc | Rat | 2-tert-butylhydroquinone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone results in increased expression of GCLC mRNA | CTD | PMID:27178040 and PMID:30806763 |
Gclc | Rat | 2-tert-butylhydroquinone | increases expression | EXP | | 6480464 | 2-tert-butylhydroquinone results in increased expression of GCLC mRNA | CTD | PMID:10978506 |
Gclc | Rat | 2-tert-butylhydroquinone | increases activity | ISO | Gclc (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased activity of GCLC protein | CTD | PMID:7955076 |
Gclc | Rat | 2-tert-butylhydroquinone | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-tert-butylhydroquinone affects the expression of GCLC mRNA | CTD | PMID:15946948 |
Gclc | Rat | 2-tert-butylhydroquinone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 2-tert-butylhydroquinone results in increased expression of GCLC mRNA | CTD | PMID:12007577 more ... |
Gclc | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 |
Gclc | Rat | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:23994337 |
Gclc | Rat | 3,3',5,5'-tetrabromobisphenol A | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [tetrabromobisphenol A results in increased expression of GCLC mRNA] | CTD | PMID:30951941 |
Gclc | Rat | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | tetrabromobisphenol A results in increased expression of GCLC mRNA | CTD | PMID:30951941 |
Gclc | Rat | 3,4-methylenedioxymethamphetamine | multiple interactions | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine inhibits the reaction [sulforaphane results in increased expression of GCLC mRNA] | CTD | PMID:21871945 |
Gclc | Rat | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of GCLC mRNA | CTD | PMID:28522335 |
Gclc | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GCLC mRNA more ... | CTD | PMID:16054899 and PMID:33412187 |
Gclc | Rat | 3-nitropropanoic acid | multiple interactions | EXP | | 6480464 | [naringin co-treated with 3-nitropropionic acid] results in increased expression of GCLC mRNA | CTD | PMID:22871521 |
Gclc | Rat | 3-O-Caffeoyl-1-O-methylquinic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GCLC mRNA] | CTD | PMID:16631525 |
Gclc | Rat | 3-O-Caffeoyl-1-O-methylquinic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 3-O-caffeoyl-1-methylquinic acid results in increased expression of GCLC mRNA | CTD | PMID:16631525 |
Gclc | Rat | 3-phenylprop-2-enal | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cinnamaldehyde results in increased expression of GCLC protein] more ... | CTD | PMID:20351055 and PMID:21469739 |
Gclc | Rat | 3-phenylprop-2-enal | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cinnamaldehyde results in increased expression of GCLC mRNA and cinnamaldehyde results in increased expression of GCLC protein | CTD | PMID:17178418 more ... |
Gclc | Rat | 3H-1,2-dithiole-3-thione | multiple interactions | EXP | | 6480464 | [1 and 2-dithiol-3-thione results in increased activity of GCLC protein] which results in decreased susceptibility to Acrolein | CTD | PMID:12535742 |
Gclc | Rat | 3H-1,2-dithiole-3-thione | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of GCLC mRNA | CTD | PMID:19073213 and PMID:19408115 |
Gclc | Rat | 3H-1,2-dithiole-3-thione | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:18367636 and PMID:22959925 |
Gclc | Rat | 3H-1,2-dithiole-3-thione | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:18367636 and PMID:22495766 |
Gclc | Rat | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of GCLC mRNA | CTD | PMID:15946642 |
Gclc | Rat | 3H-1,2-dithiole-3-thione | increases activity | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in increased activity of GCLC protein | CTD | PMID:12535742 |
Gclc | Rat | 4,4'-methylene-bis-(2-chloroaniline) | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Methylenebis(chloroaniline) results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | 4,4'-sulfonyldiphenol | affects expression | ISO | Gclc (Mus musculus) | 6480464 | bisphenol S affects the expression of GCLC mRNA | CTD | PMID:39298647 |
Gclc | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | bisphenol S results in increased expression of GCLC mRNA | CTD | PMID:33297965 |
Gclc | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [bisphenol S co-treated with cylindrospermopsin] results in increased expression of GCLC mRNA | CTD | PMID:32244372 |
Gclc | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
Gclc | Rat | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2 and 6-dinitrotoluene affects the expression of GCLC mRNA | CTD | PMID:21346803 |
Gclc | Rat | 4-hydroxy-TEMPO | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [tempol inhibits the reaction [lipopolysaccharide more ... | CTD | PMID:38454815 |
Gclc | Rat | 4-hydroxy-TEMPO | multiple interactions | EXP | | 6480464 | tempol inhibits the reaction [Aldosterone results in increased expression of GCLC protein] | CTD | PMID:24512358 and PMID:25204689 |
Gclc | Rat | 4-hydroxynon-2-enal | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of GCLC mRNA | CTD | PMID:19191707 |
Gclc | Rat | 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of GCLC protein | CTD | PMID:24291486 |
Gclc | Rat | 4-hydroxynon-2-enal | multiple interactions | EXP | | 6480464 | NFE2L2 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of GCLC mRNA] | CTD | PMID:24291486 |
Gclc | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Fenretinide results in increased expression of GCLC mRNA | CTD | PMID:28973697 |
Gclc | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Fenretinide results in increased expression of GCLC mRNA | CTD | PMID:21319187 |
Gclc | Rat | 4-hydroxyphenyl retinamide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Fenretinide co-treated with scriptaid] results in increased expression of GCLC mRNA and [Fenretinide co-treated with trichostatin A] results in increased expression of GCLC mRNA | CTD | PMID:21319187 |
Gclc | Rat | 4-nitro-1,2-phenylenediamine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 1 and 2-diamino-4-nitrobenzene results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | 4-phenyl-3-furoxancarbonitrile | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 4-phenyl-3-furoxancarbonitrile results in increased expression of GCLC mRNA | CTD | PMID:22851183 |
Gclc | Rat | 4-phenyl-3-furoxancarbonitrile | increases expression | ISO | Gclc (Mus musculus) | 6480464 | 4-phenyl-3-furoxancarbonitrile analog results in increased expression of GCLC mRNA | CTD | PMID:22851183 |
Gclc | Rat | 5-(hydroxymethyl)cytosine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [hydroquinone affects the methylation of GCLC promoter] which results in increased abundance of 5-hydroxymethylcytosine | CTD | PMID:23940045 |
Gclc | Rat | 5-bromo-2'-deoxyuridine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Bromodeoxyuridine co-treated with furan] results in increased expression of GCLC mRNA | CTD | PMID:24910943 |
Gclc | Rat | 5-methylcytosine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [hydroquinone affects the methylation of GCLC promoter] which results in decreased abundance of 5-Methylcytosine | CTD | PMID:23940045 |
Gclc | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of GCLC mRNA | CTD | PMID:30047161 |
Gclc | Rat | 7,8-dihydroxycoumarin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | daphnetin results in increased expression of GCLC protein | CTD | PMID:30738023 |
Gclc | Rat | [6]-Shogaol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | shogaol results in increased expression of GCLC mRNA | CTD | PMID:25148906 |
Gclc | Rat | [6]-Shogaol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | shogaol metabolite results in increased expression of GCLC protein and shogaol results in increased expression of GCLC protein | CTD | PMID:25148906 |
Gclc | Rat | [6]-Shogaol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [shogaol results in increased expression of GCLC mRNA] | CTD | PMID:25148906 |
Gclc | Rat | acetaldehyde | increases expression | EXP | | 6480464 | Acetaldehyde results in increased expression of GCLC mRNA | CTD | PMID:11439094 |
Gclc | Rat | acetic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Acetic Acid results in increased expression of GCLC mRNA | CTD | PMID:35750087 |
Gclc | Rat | acetylcholine | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC promoter SNP results in decreased susceptibility to Acetylcholine | CTD | PMID:12598062 |
Gclc | Rat | acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of GCLC mRNA | CTD | PMID:25145656 and PMID:38090360 |
Gclc | Rat | acrolein | multiple interactions | EXP | | 6480464 | [1 and 2-dithiol-3-thione results in increased activity of GCLC protein] which results in decreased susceptibility to Acrolein | CTD | PMID:12535742 |
Gclc | Rat | acrolein | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Acrolein results in increased expression of GCLC mRNA | CTD | PMID:12084617 and PMID:28109747 |
Gclc | Rat | acrylamide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Acrylamide results in increased expression of GCLC mRNA | CTD | PMID:32763439 |
Gclc | Rat | acrylamide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | IL1B gene mutant form inhibits the reaction [Acrylamide results in increased expression of GCLC mRNA] | CTD | PMID:37540211 |
Gclc | Rat | acrylamide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Acrylamide results in increased expression of GCLC mRNA | CTD | PMID:37540211 |
Gclc | Rat | actinomycin D | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of GCLC protein and Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA] | CTD | PMID:11972604 and PMID:38460933 |
Gclc | Rat | actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [notoginsenoside R1 results in increased expression of GCLC protein] | CTD | PMID:24437944 |
Gclc | Rat | Aescin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLC protein] | CTD | PMID:36905866 |
Gclc | Rat | Aescin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Escin results in increased expression of GCLC protein | CTD | PMID:36905866 |
Gclc | Rat | Aescin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Escin inhibits the reaction [Dietary Fats results in decreased expression of GCLC protein] more ... | CTD | PMID:36905866 |
Gclc | Rat | Aescin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Escin results in increased expression of GCLC protein | CTD | PMID:36905866 |
Gclc | Rat | aflatoxin B1 | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of GCLC mRNA | CTD | PMID:19770486 |
Gclc | Rat | aflatoxin B1 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of GCLC mRNA] | CTD | PMID:35063475 |
Gclc | Rat | aflatoxin B1 | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of GCLC mRNA | CTD | PMID:35063475 |
Gclc | Rat | aflatoxin B1 | decreases methylation | ISO | GCLC (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of GCLC gene | CTD | PMID:27153756 |
Gclc | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GCLC mRNA | CTD | PMID:15890375 more ... |
Gclc | Rat | alachlor | increases expression | EXP | | 6480464 | alachlor results in increased expression of GCLC protein | CTD | PMID:14563481 |
Gclc | Rat | alcohol | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Alcohols results in decreased expression of GCLC mRNA | CTD | PMID:18814483 |
Gclc | Rat | alcohol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Vitamin E inhibits the reaction [Alcohols results in increased expression of GCLC mRNA] | CTD | PMID:18814483 |
Gclc | Rat | aldehydo-D-glucosamine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Glucosamine analog results in increased expression of GCLC mRNA | CTD | PMID:21825963 |
Gclc | Rat | aldehydo-D-glucose | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | aldehydo-D-glucose | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | aldosterone | increases expression | EXP | | 6480464 | Aldosterone results in increased expression of GCLC protein | CTD | PMID:24512358 and PMID:25204689 |
Gclc | Rat | aldosterone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Aldosterone results in increased expression of GCLC protein] and tempol inhibits the reaction [Aldosterone results in increased expression of GCLC protein] | CTD | PMID:24512358 and PMID:25204689 |
Gclc | Rat | all-trans-retinal | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Retinaldehyde results in increased expression of GCLC mRNA | CTD | PMID:25331497 and PMID:27751755 |
Gclc | Rat | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of GCLC mRNA and Tretinoin results in decreased expression of GCLC protein | CTD | PMID:30267739 |
Gclc | Rat | all-trans-retinoic acid | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GCLC mRNA | CTD | PMID:33167477 |
Gclc | Rat | all-trans-retinoic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | alpha-pyrrolidinononanophenone analog promotes the reaction [Tretinoin results in increased expression of GCLC mRNA] | CTD | PMID:38040126 |
Gclc | Rat | all-trans-retinoic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Tretinoin results in increased expression of GCLC mRNA | CTD | PMID:38040126 |
Gclc | Rat | allethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein | CTD | PMID:34896426 |
Gclc | Rat | alloxan | multiple interactions | EXP | | 6480464 | ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC mRNA] more ... | CTD | PMID:33359794 |
Gclc | Rat | alloxan | decreases expression | EXP | | 6480464 | Alloxan results in decreased expression of GCLC mRNA and Alloxan results in decreased expression of GCLC protein | CTD | PMID:33359794 |
Gclc | Rat | allyl isothiocyanate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [allyl isothiocyanate results in increased expression of GCLC mRNA] | CTD | PMID:24036144 |
Gclc | Rat | allyl isothiocyanate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | allyl isothiocyanate results in increased expression of GCLC mRNA | CTD | PMID:24036144 |
Gclc | Rat | allyl isothiocyanate | increases activity | ISO | Gclc (Mus musculus) | 6480464 | allyl isothiocyanate results in increased activity of GCLC protein | CTD | PMID:24036144 |
Gclc | Rat | allyl methyl disulfide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of GCLC protein] | CTD | PMID:37995826 |
Gclc | Rat | alpha,alpha-trehalose | multiple interactions | EXP | | 6480464 | Trehalose inhibits the reaction [cadmium acetate results in increased expression of GCLC protein] | CTD | PMID:29140578 |
Gclc | Rat | alpha-D-galactose | multiple interactions | EXP | | 6480464 | Saponins inhibits the reaction [Galactose results in decreased expression of GCLC mRNA] | CTD | PMID:25892055 |
Gclc | Rat | alpha-D-galactose | decreases expression | EXP | | 6480464 | Galactose results in decreased expression of GCLC mRNA | CTD | PMID:25892055 |
Gclc | Rat | alpha-hexylcinnamaldehyde | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | hexyl cinnamic aldehyde results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | alpha-linolenic acid | increases activity | ISO | GCLC (Homo sapiens) | 6480464 | alpha-Linolenic Acid results in increased activity of GCLC protein | CTD | PMID:17092368 |
Gclc | Rat | alpha-linolenic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | alpha-Linolenic Acid results in increased expression of GCLC mRNA | CTD | PMID:17092368 |
Gclc | Rat | alpha-Solamarine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of GCLC protein] | CTD | PMID:35350913 |
Gclc | Rat | Altertoxin II | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | altertoxin II affects the expression of GCLC mRNA | CTD | PMID:27178040 |
Gclc | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of GCLC mRNA | CTD | PMID:30047161 |
Gclc | Rat | amlexanox | increases expression | ISO | Gclc (Mus musculus) | 6480464 | amlexanox results in increased expression of GCLC mRNA | CTD | PMID:31697998 |
Gclc | Rat | amlexanox | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLC mRNA and [Acetaminophen co-treated with amlexanox] affects the expression of GCLC mRNA | CTD | PMID:31697998 |
Gclc | Rat | ampicillin | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Ampicillin results in decreased expression of GCLC mRNA | CTD | PMID:21632981 and PMID:26198647 |
Gclc | Rat | andrographolide | increases expression | EXP | | 6480464 | andrographolide results in increased expression of GCLC mRNA and andrographolide results in increased expression of GCLC protein | CTD | PMID:25110055 and PMID:29355602 |
Gclc | Rat | andrographolide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [andrographolide co-treated with TNF protein] results in increased expression of GCLC mRNA | CTD | PMID:35724838 |
Gclc | Rat | andrographolide | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | andrographolide results in decreased expression of GCLC mRNA | CTD | PMID:35724838 |
Gclc | Rat | andrographolide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | andrographolide inhibits the reaction [Acetaminophen results in decreased expression of GCLC mRNA] | CTD | PMID:29355602 |
Gclc | Rat | andrographolide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | andrographolide results in increased expression of GCLC protein | CTD | PMID:29355602 |
Gclc | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [[clivorine co-treated with Quercetin] results in increased expression of GCLC mRNA] more ... | CTD | PMID:21469739 and PMID:25881548 |
Gclc | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | pyrazolanthrone inhibits the reaction [Ozone results in increased expression of GCLC mRNA] and pyrazolanthrone promotes the reaction [arsenite results in increased expression of GCLC mRNA] | CTD | PMID:17460151 and PMID:19328227 |
Gclc | Rat | antimonite | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA | CTD | PMID:32076005 |
Gclc | Rat | antimony(0) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony] | CTD | PMID:11560771 |
Gclc | Rat | apigenin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Apigenin results in increased expression of GCLC mRNA | CTD | PMID:11864778 |
Gclc | Rat | apigenin | increases expression | EXP | | 6480464 | Apigenin results in increased expression of GCLC mRNA and Apigenin results in increased expression of GCLC protein | CTD | PMID:22864849 |
Gclc | Rat | apigenin | multiple interactions | EXP | | 6480464 | [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:22864849 |
Gclc | Rat | arachidonic acid | increases activity | ISO | GCLC (Homo sapiens) | 6480464 | Arachidonic Acid results in increased activity of GCLC protein | CTD | PMID:17092368 |
Gclc | Rat | arachidonic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Arachidonic Acid results in increased expression of GCLC mRNA | CTD | PMID:16704987 and PMID:17092368 |
Gclc | Rat | Aroclor 1254 | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of GCLC mRNA | CTD | PMID:23650126 |
Gclc | Rat | arotinoid acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gclc | Rat | arsane | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Arsenic results in increased expression of GCLC mRNA and Arsenic results in increased expression of GCLC protein | CTD | PMID:18487201 more ... |
Gclc | Rat | arsane | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC mRNA more ... | CTD | PMID:29751399 more ... |
Gclc | Rat | arsane | affects response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC gene SNP affects the susceptibility to Arsenic | CTD | PMID:29751399 |
Gclc | Rat | arsane | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Arsenic results in increased expression of GCLC mRNA and Arsenic results in increased expression of GCLC protein | CTD | PMID:23000044 and PMID:35523338 |
Gclc | Rat | arsane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of GCLC mRNA] and NFE2L2 protein affects the reaction [Arsenic results in increased expression of GCLC protein] | CTD | PMID:23000044 and PMID:35523338 |
Gclc | Rat | arsenic atom | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Arsenic results in increased expression of GCLC mRNA and Arsenic results in increased expression of GCLC protein | CTD | PMID:18487201 more ... |
Gclc | Rat | arsenic atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC mRNA more ... | CTD | PMID:29751399 more ... |
Gclc | Rat | arsenic atom | affects response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC gene SNP affects the susceptibility to Arsenic | CTD | PMID:29751399 |
Gclc | Rat | arsenic atom | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of GCLC mRNA] and NFE2L2 protein affects the reaction [Arsenic results in increased expression of GCLC protein] | CTD | PMID:23000044 and PMID:35523338 |
Gclc | Rat | arsenic atom | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Arsenic results in increased expression of GCLC mRNA and Arsenic results in increased expression of GCLC protein | CTD | PMID:23000044 and PMID:35523338 |
Gclc | Rat | arsenite(3-) | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [arsenite results in increased expression of GCLC mRNA] more ... | CTD | PMID:15894712 more ... |
Gclc | Rat | arsenite(3-) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [arsenite co-treated with epigallocatechin gallate] results in increased expression of GCLC protein more ... | CTD | PMID:22476201 more ... |
Gclc | Rat | arsenite(3-) | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | arsenite results in increased expression of GCLC mRNA and arsenite results in increased expression of GCLC protein | CTD | PMID:22476201 |
Gclc | Rat | arsenite(3-) | increases expression | ISO | Gclc (Mus musculus) | 6480464 | arsenite results in increased expression of GCLC mRNA and arsenite results in increased expression of GCLC protein | CTD | PMID:15894712 more ... |
Gclc | Rat | arsenous acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC mRNA and [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC protein | CTD | PMID:33434570 |
Gclc | Rat | arsenous acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of GCLC mRNA] | CTD | PMID:29049341 |
Gclc | Rat | arsenous acid | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 and PMID:29549912 |
Gclc | Rat | arsenous acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of GCLC mRNA | CTD | PMID:29049341 |
Gclc | Rat | arsenous acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GCLC mRNA and Arsenic Trioxide results in increased expression of GCLC protein | CTD | PMID:19417148 more ... |
Gclc | Rat | arsenous acid | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of GCLC protein | CTD | PMID:25341331 and PMID:25419056 |
Gclc | Rat | artesunate | affects response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC mRNA affects the susceptibility to artesunate | CTD | PMID:15796179 |
Gclc | Rat | artesunate | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC mRNA results in decreased susceptibility to artesunate | CTD | PMID:15796179 |
Gclc | Rat | astilbin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | astilbin inhibits the reaction [Cisplatin results in decreased expression of GCLC mRNA] | CTD | PMID:29471006 |
Gclc | Rat | atrazine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Atrazine results in increased expression of GCLC mRNA | CTD | PMID:36216167 |
Gclc | Rat | atrazine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of GCLC mRNA] | CTD | PMID:36216167 |
Gclc | Rat | Augmentin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA | CTD | PMID:34767876 |
Gclc | Rat | azathioprine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Azathioprine results in increased expression of GCLC mRNA | CTD | PMID:22623647 and PMID:26198647 |
Gclc | Rat | Azoxymethane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLC mRNA | CTD | PMID:29950665 |
Gclc | Rat | Bandrowski's base | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Bandrowski's base results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | Bardoxolone methyl | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | bardoxolone methyl results in increased expression of GCLC mRNA and bardoxolone methyl results in increased expression of GCLC protein | CTD | PMID:27480280 and PMID:34480604 |
Gclc | Rat | Bardoxolone methyl | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | bardoxolone methyl results in decreased expression of GCLC mRNA | CTD | PMID:35724838 |
Gclc | Rat | bellidifolin | increases expression | EXP | | 6480464 | bellidifolin results in increased expression of GCLC mRNA and bellidifolin results in increased expression of GCLC protein | CTD | PMID:30800665 |
Gclc | Rat | benzalkonium chloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Benzalkonium Compounds results in increased expression of GCLC mRNA | CTD | PMID:30806763 |
Gclc | Rat | benzene | affects expression | EXP | | 6480464 | Benzene affects the expression of GCLC mRNA | CTD | PMID:15878777 |
Gclc | Rat | benzene | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Deferoxamine inhibits the reaction [Benzene results in decreased expression of GCLC mRNA] and ferrostatin-1 inhibits the reaction [Benzene results in decreased expression of GCLC mRNA] | CTD | PMID:35661779 |
Gclc | Rat | benzene | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Benzene results in decreased expression of GCLC mRNA | CTD | PMID:35661779 |
Gclc | Rat | benzidine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | benzidine results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | benzo[a]pyrene | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Cadmium Chloride co-treated with Benzo(a)pyrene] results in increased expression of GCLC mRNA | CTD | PMID:25170436 |
Gclc | Rat | benzo[a]pyrene | increases methylation | ISO | GCLC (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of GCLC promoter | CTD | PMID:27901495 |
Gclc | Rat | benzo[a]pyrene | decreases methylation | ISO | GCLC (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of GCLC 3' UTR | CTD | PMID:27901495 |
Gclc | Rat | benzo[a]pyrene | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:20106945 more ... |
Gclc | Rat | benzo[a]pyrene | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:14625279 more ... |
Gclc | Rat | benzo[a]pyrene | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GCLC mRNA more ... | CTD | PMID:14625279 more ... |
Gclc | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 |
Gclc | Rat | benzoic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Benzoic Acid results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | benzoquinones | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Benzoquinones analog results in increased expression of GCLC protein | CTD | PMID:21651925 |
Gclc | Rat | berberine | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Bortezomib results in increased expression of GCLC mRNA] | CTD | PMID:35121005 |
Gclc | Rat | beta-D-glucosamine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Glucosamine analog results in increased expression of GCLC mRNA | CTD | PMID:21825963 |
Gclc | Rat | beta-naphthoflavone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
Gclc | Rat | beta-naphthoflavone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | beta-Naphthoflavone results in increased expression of GCLC mRNA | CTD | PMID:16426233 and PMID:23994337 |
Gclc | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of GCLC mRNA | CTD | PMID:35917956 more ... |
Gclc | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA and Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GCLC mRNA] | CTD | PMID:35917956 more ... |
Gclc | Rat | bisphenol A | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | bisphenol A affects the expression of GCLC mRNA | CTD | PMID:20170705 and PMID:30903817 |
Gclc | Rat | bisphenol A | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:37364641 and PMID:39117098 |
Gclc | Rat | bisphenol A | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [bisphenol A co-treated with cylindrospermopsin] results in increased expression of GCLC mRNA | CTD | PMID:32244372 |
Gclc | Rat | bisphenol A | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GCLC mRNA | CTD | PMID:30547568 more ... |
Gclc | Rat | bisphenol A | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | bisphenol A results in increased expression of GCLC and bisphenol A results in increased expression of GCLC protein | CTD | PMID:31207516 and PMID:34186270 |
Gclc | Rat | bisphenol A | increases expression | ISO | Gclc (Mus musculus) | 6480464 | bisphenol A results in increased expression of GCLC mRNA and bisphenol A results in increased expression of GCLC protein | CTD | PMID:28796629 |
Gclc | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GCLC mRNA | CTD | PMID:25181051 more ... |
Gclc | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GCLC mRNA | CTD | PMID:26496021 |
Gclc | Rat | bisphenol AF | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [bisphenol AF co-treated with cylindrospermopsin] results in increased expression of GCLC mRNA | CTD | PMID:32244372 |
Gclc | Rat | Bisphenol B | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | bisphenol B results in increased expression of GCLC protein | CTD | PMID:34186270 |
Gclc | Rat | bisphenol F | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [bisphenol F co-treated with cylindrospermopsin] results in increased expression of GCLC mRNA | CTD | PMID:32244372 |
Gclc | Rat | bisphenol F | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | bisphenol F results in increased expression of GCLC protein | CTD | PMID:34186270 |
Gclc | Rat | bleomycin A2 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of GCLC protein] | CTD | PMID:23570914 |
Gclc | Rat | bleomycin A2 | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Bleomycin results in decreased expression of GCLC protein | CTD | PMID:23570914 |
Gclc | Rat | bleomycin A5 | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | bleomycetin results in increased expression of GCLC mRNA | CTD | PMID:21040473 |
Gclc | Rat | boric acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | boric acid results in increased expression of GCLC mRNA | CTD | PMID:30196486 |
Gclc | Rat | boric acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | boric acid results in increased expression of GCLC mRNA | CTD | PMID:30196486 |
Gclc | Rat | boric acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | EIF2AK3 protein affects the reaction [boric acid results in increased expression of GCLC mRNA] | CTD | PMID:30196486 |
Gclc | Rat | bortezomib | increases expression | EXP | | 6480464 | Bortezomib results in increased expression of GCLC mRNA | CTD | PMID:35121005 |
Gclc | Rat | bortezomib | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Bortezomib results in increased expression of GCLC mRNA] | CTD | PMID:35121005 |
Gclc | Rat | bosentan | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Bosentan results in increased expression of GCLC mRNA | CTD | PMID:29761207 |
Gclc | Rat | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of GCLC protein | CTD | PMID:28903499 |
Gclc | Rat | bromobenzene | increases expression | ISO | Gclc (Mus musculus) | 6480464 | bromobenzene results in increased expression of GCLC protein | CTD | PMID:18078705 |
Gclc | Rat | Bromochloroacetonitrile | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | bromochloroacetonitrile results in increased expression of GCLC mRNA | CTD | PMID:35842135 |
Gclc | Rat | Brusatol | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | brusatol results in decreased expression of GCLC protein | CTD | PMID:27639429 |
Gclc | Rat | buspirone | decreases expression | EXP | | 6480464 | Buspirone results in decreased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | buta-1,3-diene | affects expression | ISO | Gclc (Mus musculus) | 6480464 | 1 and 3-butadiene affects the expression of GCLC mRNA | CTD | PMID:29038090 |
Gclc | Rat | butanal | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of GCLC mRNA | CTD | PMID:26079696 |
Gclc | Rat | butane-2,3-dione | increases expression | EXP | | 6480464 | Diacetyl results in increased expression of GCLC mRNA | CTD | PMID:25145656 |
Gclc | Rat | butylated hydroxyanisole | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Butylated Hydroxyanisole results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
Gclc | Rat | butylated hydroxyanisole | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Butylated Hydroxyanisole results in increased expression of GCLC mRNA and Butylated Hydroxyanisole results in increased expression of GCLC protein | CTD | PMID:16426233 and PMID:25922074 |
Gclc | Rat | Butylbenzyl phthalate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA | CTD | PMID:37364641 |
Gclc | Rat | cadmium acetate | increases expression | EXP | | 6480464 | cadmium acetate results in increased expression of GCLC protein | CTD | PMID:29140578 |
Gclc | Rat | cadmium acetate | multiple interactions | EXP | | 6480464 | Trehalose inhibits the reaction [cadmium acetate results in increased expression of GCLC protein] | CTD | PMID:29140578 |
Gclc | Rat | cadmium atom | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cadmium results in increased expression of GCLC mRNA | CTD | PMID:21120746 |
Gclc | Rat | cadmium atom | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Cadmium results in increased expression of GCLC mRNA | CTD | PMID:26363317 |
Gclc | Rat | cadmium atom | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Cadmium results in decreased expression of GCLC mRNA | CTD | PMID:37270049 |
Gclc | Rat | cadmium atom | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCLC mRNA more ... | CTD | PMID:33398418 |
Gclc | Rat | cadmium atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GCLC protein and [GCLC results in decreased uptake of Cadmium] which results in decreased expression of SLC39A8 | CTD | PMID:18556457 and PMID:30359721 |
Gclc | Rat | cadmium atom | increases expression | EXP | | 6480464 | Cadmium results in increased expression of GCLC and Cadmium results in increased expression of GCLC mRNA | CTD | PMID:19879314 and PMID:25388156 |
Gclc | Rat | cadmium dichloride | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Cadmium Chloride co-treated with Benzo(a)pyrene] results in increased expression of GCLC mRNA more ... | CTD | PMID:18556457 more ... |
Gclc | Rat | cadmium dichloride | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of GCLC mRNA | CTD | PMID:38568856 |
Gclc | Rat | cadmium dichloride | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of GCLC mRNA more ... | CTD | PMID:33398418 |
Gclc | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of GCLC mRNA | CTD | PMID:25993096 |
Gclc | Rat | cadmium dichloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of GCLC mRNA and Cadmium Chloride results in increased expression of GCLC protein | CTD | PMID:24291162 more ... |
Gclc | Rat | cadmium dichloride | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Cadmium Chloride results in increased expression of GCLC mRNA and Cadmium Chloride results in increased expression of GCLC protein | CTD | PMID:22677785 and PMID:29486218 |
Gclc | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of GCLC mRNA | CTD | PMID:11254161 |
Gclc | Rat | cadmium dichloride | multiple interactions | EXP | | 6480464 | Cadmium Chloride results in increased expression of and results in increased activity of GCLC protein and GCLC affects the reaction [NFE2L2 protein results in decreased susceptibility to Cadmium Chloride] | CTD | PMID:11254161 and PMID:19682480 |
Gclc | Rat | cadmium dichloride | decreases uptake | ISO | GCLC (Homo sapiens) | 6480464 | GCLC results in decreased uptake of Cadmium Chloride | CTD | PMID:18556457 |
Gclc | Rat | cadmium dichloride | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC results in decreased susceptibility to Cadmium Chloride | CTD | PMID:18556457 |
Gclc | Rat | cadmium sulfate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GCLC mRNA | CTD | PMID:18654764 |
Gclc | Rat | cadmium sulfate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | cadmium sulfate results in increased expression of GCLC mRNA | CTD | PMID:16221973 |
Gclc | Rat | cadmium sulfate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cadmium sulfate results in increased expression of GCLC mRNA | CTD | PMID:12064557 |
Gclc | Rat | cadmium sulfide | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | cadmium sulfide results in decreased expression of GCLC mRNA | CTD | PMID:27866839 |
Gclc | Rat | cafestol | multiple interactions | EXP | | 6480464 | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GCLC protein] | CTD | PMID:17110534 |
Gclc | Rat | caffeine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GCLC mRNA | CTD | PMID:28843594 |
Gclc | Rat | caffeine | decreases phosphorylation | ISO | GCLC (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of GCLC protein | CTD | PMID:35688186 |
Gclc | Rat | calcitriol | multiple interactions | EXP | | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of GCLC mRNA | CTD | PMID:15913539 |
Gclc | Rat | calcium atom | multiple interactions | EXP | | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of GCLC mRNA | CTD | PMID:15913539 |
Gclc | Rat | calcium(0) | multiple interactions | EXP | | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of GCLC mRNA | CTD | PMID:15913539 |
Gclc | Rat | cannabidiol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of GCLC mRNA | CTD | PMID:31518892 |
Gclc | Rat | captan | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Captan results in increased expression of GCLC mRNA | CTD | PMID:31558096 |
Gclc | Rat | carbamazepine | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Carbamazepine affects the expression of GCLC mRNA | CTD | PMID:24752500 |
Gclc | Rat | carbon disulfide | increases expression | EXP | | 6480464 | Carbon Disulfide results in increased expression of GCLC mRNA | CTD | PMID:27530093 |
Gclc | Rat | carbon monoxide | increases expression | EXP | | 6480464 | Carbon Monoxide results in increased expression of GCLC mRNA | CTD | PMID:34032369 |
Gclc | Rat | carbon monoxide | multiple interactions | EXP | | 6480464 | [NFE2L2 protein co-treated with Carbon Monoxide] results in increased expression of GCLC mRNA | CTD | PMID:34032369 |
Gclc | Rat | carbon nanotube | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 |
Gclc | Rat | carbon nanotube | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 |
Gclc | Rat | carmustine | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine co-treated with Carmustine] results in decreased activity of GCLC protein and [Carmustine co-treated with Buthionine Sulfoximine] results in decreased activity of GCLC protein | CTD | PMID:12967637 and PMID:16288907 |
Gclc | Rat | carnosic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvin results in increased expression of GCLC protein] more ... | CTD | PMID:25446857 more ... |
Gclc | Rat | carnosic acid | multiple interactions | EXP | | 6480464 | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLC protein] | CTD | PMID:25446857 |
Gclc | Rat | carnosic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | salvin results in increased expression of GCLC mRNA | CTD | PMID:18329808 |
Gclc | Rat | carnosic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | salvin results in increased expression of GCLC protein | CTD | PMID:26577515 and PMID:26686574 |
Gclc | Rat | Carnosol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | carnosol results in increased expression of GCLC mRNA | CTD | PMID:20116392 |
Gclc | Rat | celastrol | multiple interactions | EXP | | 6480464 | celastrol inhibits the reaction [Doxorubicin results in decreased expression of GCLC mRNA] and celastrol inhibits the reaction [Doxorubicin results in decreased expression of GCLC protein] | CTD | PMID:30588110 |
Gclc | Rat | ceric oxide | decreases expression | EXP | | 6480464 | ceric oxide results in decreased expression of GCLC mRNA | CTD | PMID:29463257 |
Gclc | Rat | cerium trichloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cerous chloride results in increased expression of GCLC mRNA | CTD | PMID:28954213 |
Gclc | Rat | cerium trichloride | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [cerous chloride co-treated with lanthanum chloride] results in increased expression of GCLC mRNA | CTD | PMID:28954213 |
Gclc | Rat | chenodeoxycholic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Chenodeoxycholic Acid results in increased expression of GCLC protein] which results in increased abundance of Glutathione | CTD | PMID:17724089 |
Gclc | Rat | chenodeoxycholic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Chenodeoxycholic Acid results in increased expression of GCLC protein | CTD | PMID:17724089 |
Gclc | Rat | CHIR 99021 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gclc | Rat | chlorambucil | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Chlorambucil | CTD | PMID:10900222 |
Gclc | Rat | chloroacetaldehyde | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | chloroacetaldehyde results in increased expression of GCLC mRNA | CTD | PMID:25596134 |
Gclc | Rat | Chloroacetonitrile | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | chloroacetonitrile results in increased expression of GCLC mRNA | CTD | PMID:35842135 |
Gclc | Rat | chlorogenic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Chlorogenic Acid results in increased expression of GCLC mRNA | CTD | PMID:29136249 |
Gclc | Rat | chlorogenic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Chlorogenic Acid promotes the reaction [Acetaminophen results in increased expression of GCLC mRNA] | CTD | PMID:29136249 |
Gclc | Rat | chlorohydrocarbon | decreases activity | ISO | GCLC (Homo sapiens) | 6480464 | Hydrocarbons and Chlorinated analog results in decreased activity of GCLC protein | CTD | PMID:24355586 |
Gclc | Rat | chlorohydrocarbon | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Hydrocarbons and Chlorinated analog results in increased expression of GCLC protein] | CTD | PMID:24355586 |
Gclc | Rat | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of GCLC mRNA | CTD | PMID:23125180 |
Gclc | Rat | chloroprene | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Chloroprene results in increased expression of GCLC mRNA | CTD | PMID:23125180 |
Gclc | Rat | chlorpromazine | decreases expression | EXP | | 6480464 | Chlorpromazine results in decreased expression of GCLC mRNA | CTD | PMID:25596134 |
Gclc | Rat | chlorpyrifos | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Hydrogen inhibits the reaction [Chlorpyrifos results in decreased expression of GCLC mRNA] | CTD | PMID:32955216 |
Gclc | Rat | chlorpyrifos | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of GCLC mRNA | CTD | PMID:32955216 and PMID:37019170 |
Gclc | Rat | cholesterol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Cholesterol results in increased expression of GCLC protein | CTD | PMID:29486218 |
Gclc | Rat | choline | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA and NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA] | CTD | PMID:20350562 |
Gclc | Rat | chromium atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [chromous chloride results in increased abundance of Chromium] which results in decreased expression of GCLC protein | CTD | PMID:30359721 |
Gclc | Rat | chromium trinitrate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | chromium nitrate results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
Gclc | Rat | chromium(6+) | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Arsenates co-treated with chromium hexavalent ion] results in increased expression of GCLC mRNA more ... | CTD | PMID:19895865 and PMID:25820237 |
Gclc | Rat | chromium(6+) | increases expression | EXP | | 6480464 | chromium hexavalent ion results in increased expression of GCLC protein | CTD | PMID:18306314 |
Gclc | Rat | chrysin | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] more ... | CTD | PMID:22864849 and PMID:33121995 |
Gclc | Rat | chrysin | increases expression | EXP | | 6480464 | chrysin results in increased expression of GCLC mRNA and chrysin results in increased expression of GCLC protein | CTD | PMID:22864849 |
Gclc | Rat | cidofovir anhydrous | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cidofovir results in decreased expression of GCLC mRNA | CTD | PMID:25596134 |
Gclc | Rat | cinnamyl alcohol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cinnamyl alcohol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | ciprofibrate | decreases activity | EXP | | 6480464 | ciprofibrate results in decreased activity of GCLC protein | CTD | PMID:7676460 |
Gclc | Rat | ciprofibrate | decreases expression | EXP | | 6480464 | ciprofibrate results in decreased expression of GCLC mRNA | CTD | PMID:7676460 |
Gclc | Rat | cisplatin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | astilbin inhibits the reaction [Cisplatin results in decreased expression of GCLC mRNA] more ... | CTD | PMID:17628013 more ... |
Gclc | Rat | cisplatin | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein results in decreased susceptibility to Cisplatin | CTD | PMID:29549912 |
Gclc | Rat | cisplatin | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Cisplatin results in decreased expression of GCLC mRNA | CTD | PMID:32428544 |
Gclc | Rat | cisplatin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GCLC mRNA | CTD | PMID:27480280 and PMID:28959534 |
Gclc | Rat | cisplatin | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of GCLC mRNA | CTD | PMID:25596134 and PMID:29471006 |
Gclc | Rat | cisplatin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Cisplatin results in increased expression of GCLC mRNA and Cisplatin results in increased expression of GCLC protein | CTD | PMID:20605904 |
Gclc | Rat | cisplatin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 2-tert-butylhydroquinone inhibits the reaction [Cisplatin results in decreased expression of GCLC mRNA] more ... | CTD | PMID:20605904 and PMID:32428544 |
Gclc | Rat | cisplatin | increases phosphorylation | ISO | Gclc (Mus musculus) | 6480464 | Cisplatin results in increased phosphorylation of GCLC protein | CTD | PMID:22006019 |
Gclc | Rat | citraconic acid | increases expression | EXP | | 6480464 | citraconic acid results in increased expression of GCLC protein | CTD | PMID:27277809 |
Gclc | Rat | citraconic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | citraconic acid results in increased expression of GCLC mRNA | CTD | PMID:27277809 |
Gclc | Rat | clavulanic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Clavulanic Acid results in increased expression of GCLC mRNA | CTD | PMID:34767876 |
Gclc | Rat | Clivoline | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [clivorine co-treated with Quercetin] results in increased expression of GCLC mRNA and pyrazolanthrone inhibits the reaction [[clivorine co-treated with Quercetin] results in increased expression of GCLC mRNA] | CTD | PMID:25881548 |
Gclc | Rat | clobetasol | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Clobetasol results in decreased expression of GCLC mRNA | CTD | PMID:16882163 |
Gclc | Rat | clodronic acid | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Clodronic Acid results in decreased expression of GCLC mRNA | CTD | PMID:25596134 |
Gclc | Rat | cobalt dichloride | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GCLC mRNA more ... | CTD | PMID:18654764 and PMID:29966676 |
Gclc | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of GCLC mRNA | CTD | PMID:24386269 |
Gclc | Rat | cobalt dichloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of GCLC mRNA | CTD | PMID:19320972 and PMID:29966676 |
Gclc | Rat | cocaine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | PRKCD protein affects the reaction [Cocaine results in increased expression of GCLC mRNA] and rottlerin promotes the reaction [Cocaine results in increased expression of GCLC mRNA] | CTD | PMID:30393195 |
Gclc | Rat | cocaine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Cocaine results in increased expression of GCLC mRNA | CTD | PMID:30393195 |
Gclc | Rat | coniferyl aldehyde | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | coniferaldehyde results in increased expression of GCLC mRNA | CTD | PMID:26275128 |
Gclc | Rat | conjugated linoleic acid | increases activity | ISO | GCLC (Homo sapiens) | 6480464 | Linoleic Acids and Conjugated results in increased activity of GCLC protein | CTD | PMID:17092368 |
Gclc | Rat | conjugated linoleic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Linoleic Acids and Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:17092368 |
Gclc | Rat | conjugated linoleic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Linoleic Acids and Conjugated results in increased expression of GCLC mRNA | CTD | PMID:17092368 |
Gclc | Rat | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of GCLC mRNA | CTD | PMID:22465980 |
Gclc | Rat | copper atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of GCLC mRNA more ... | CTD | PMID:19747488 more ... |
Gclc | Rat | copper atom | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Copper results in increased expression of GCLC mRNA | CTD | PMID:19747488 |
Gclc | Rat | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of GCLC mRNA | CTD | PMID:22465980 |
Gclc | Rat | copper(0) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Chelating Agents binds to Copper] which results in increased expression of GCLC mRNA more ... | CTD | PMID:19747488 more ... |
Gclc | Rat | copper(0) | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Copper results in increased expression of GCLC mRNA | CTD | PMID:19747488 |
Gclc | Rat | copper(II) chloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cupric chloride results in increased expression of GCLC mRNA | CTD | PMID:17211630 and PMID:38568856 |
Gclc | Rat | copper(II) sulfate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of GCLC mRNA | CTD | PMID:19549813 |
Gclc | Rat | cortisol | increases expression | EXP | | 6480464 | Hydrocortisone results in increased expression of GCLC mRNA | CTD | PMID:10978506 |
Gclc | Rat | cortisol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [4-(2-(5 more ... | CTD | PMID:34480604 |
Gclc | Rat | coumarin | increases expression | EXP | | 6480464 | coumarin results in increased expression of GCLC mRNA | CTD | PMID:18480146 |
Gclc | Rat | crocidolite asbestos | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Asbestos more ... | CTD | PMID:15520183 |
Gclc | Rat | crocidolite asbestos | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [GCLC protein co-treated with GCLM protein] inhibits the reaction [Asbestos more ... | CTD | PMID:15520183 |
Gclc | Rat | cumene hydroperoxide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | cumene hydroperoxide results in increased expression of GCLC mRNA | CTD | PMID:30547568 |
Gclc | Rat | curcumin | increases activity | ISO | GCLC (Homo sapiens) | 6480464 | Curcumin results in increased activity of GCLC protein | CTD | PMID:10514034 |
Gclc | Rat | curcumin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Curcumin inhibits the reaction [Aflatoxin B1 results in decreased expression of GCLC mRNA] more ... | CTD | PMID:29571711 more ... |
Gclc | Rat | curcumin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Curcumin analog results in increased expression of GCLC mRNA and Curcumin results in increased expression of GCLC mRNA | CTD | PMID:23710286 and PMID:23954767 |
Gclc | Rat | curcumin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Curcumin inhibits the reaction [Hydrogen Peroxide results in decreased expression of GCLC mRNA] more ... | CTD | PMID:23954767 and PMID:31521693 |
Gclc | Rat | curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of GCLC mRNA and Curcumin results in increased expression of GCLC protein | CTD | PMID:17602960 more ... |
Gclc | Rat | curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Ketamine results in decreased expression of GCLC mRNA] more ... | CTD | PMID:17602960 more ... |
Gclc | Rat | curcumin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Curcumin results in increased expression of GCLC mRNA and Curcumin results in increased expression of GCLC protein | CTD | PMID:19168576 more ... |
Gclc | Rat | cycloheximide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Cycloheximide inhibits the reaction [arsenite results in increased activity of [GCLC protein binds to GCLM protein]] more ... | CTD | PMID:17628625 and PMID:19328227 |
Gclc | Rat | cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [notoginsenoside R1 results in increased expression of GCLC protein] | CTD | PMID:24437944 |
Gclc | Rat | cyclophosphamide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Cyclophosphamide promotes the reaction [NFE2L2 gene mutant form results in decreased expression of GCLC protein] | CTD | PMID:27633142 |
Gclc | Rat | cyclophosphamide | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Cyclophosphamide results in decreased expression of GCLC mRNA and Cyclophosphamide results in decreased expression of GCLC protein | CTD | PMID:27633142 |
Gclc | Rat | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of GCLC mRNA | CTD | PMID:11589784 and PMID:25596134 |
Gclc | Rat | cyclosporin A | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of GCLC mRNA | CTD | PMID:20106945 more ... |
Gclc | Rat | cyhalothrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein | CTD | PMID:34896426 |
Gclc | Rat | cylindrospermopsin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cylindrospermopsin results in increased expression of GCLC mRNA | CTD | PMID:23726867 and PMID:32244372 |
Gclc | Rat | cylindrospermopsin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [bisphenol A co-treated with cylindrospermopsin] results in increased expression of GCLC mRNA more ... | CTD | PMID:32244372 |
Gclc | Rat | cylindrospermopsin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | cylindrospermopsin results in increased expression of GCLC mRNA | CTD | PMID:20936652 |
Gclc | Rat | cypermethrin | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein | CTD | PMID:34896426 |
Gclc | Rat | cysteamine | decreases activity | ISO | Gclc (Mus musculus) | 6480464 | Cysteamine results in decreased activity of GCLC protein | CTD | PMID:15282320 |
Gclc | Rat | cysteamine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Cysteamine results in decreased activity of GCLC protein] which results in decreased abundance of Glutathione | CTD | PMID:15282320 |
Gclc | Rat | D-glucose | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | D-glucose | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | DDE | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC mRNA] more ... | CTD | PMID:25263748 |
Gclc | Rat | DDE | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC mRNA and Dichlorodiphenyl Dichloroethylene results in decreased expression of GCLC protein | CTD | PMID:25263748 |
Gclc | Rat | DDT | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | DDT results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | DDT | increases expression | EXP | | 6480464 | DDT results in increased expression of GCLC mRNA | CTD | PMID:29477483 |
Gclc | Rat | deguelin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | deguelin results in increased expression of GCLC mRNA | CTD | PMID:33512557 |
Gclc | Rat | deoxycholic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Deoxycholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA | CTD | PMID:17724089 |
Gclc | Rat | Deoxycorticosterone acetate | multiple interactions | EXP | | 6480464 | [Desoxycorticosterone Acetate co-treated with Sodium Chloride and Dietary co-treated with Potassium Chloride] results in decreased expression of GCLC mRNA | CTD | PMID:22228705 |
Gclc | Rat | deoxynivalenol | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | deoxynivalenol results in decreased expression of GCLC mRNA | CTD | PMID:35817260 |
Gclc | Rat | deoxynivalenol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of GCLC protein] | CTD | PMID:37419272 |
Gclc | Rat | deoxynivalenol | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of GCLC mRNA and deoxynivalenol results in decreased expression of GCLC protein | CTD | PMID:37419272 and PMID:39147090 |
Gclc | Rat | deoxynivalenol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Curcumin inhibits the reaction [deoxynivalenol results in decreased expression of GCLC mRNA] | CTD | PMID:35817260 |
Gclc | Rat | desferrioxamine B | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Deferoxamine inhibits the reaction [Benzene results in decreased expression of GCLC mRNA] | CTD | PMID:35661779 |
Gclc | Rat | dexamethasone | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GCLC mRNA more ... | CTD | PMID:16054899 and PMID:33412187 |
Gclc | Rat | dexamethasone | multiple interactions | EXP | | 6480464 | [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of GCLC mRNA more ... | CTD | PMID:27028516 |
Gclc | Rat | dextran sulfate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLC mRNA | CTD | PMID:29950665 |
Gclc | Rat | dextromethorphan | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | PRKCD protein affects the reaction [Dextromethorphan affects the expression of GCLC mRNA] more ... | CTD | PMID:34740715 |
Gclc | Rat | dextromethorphan | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Dextromethorphan affects the expression of GCLC mRNA | CTD | PMID:34740715 |
Gclc | Rat | Di-n-octyl phthalate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA | CTD | PMID:37364641 |
Gclc | Rat | diallyl disulfide | multiple interactions | EXP | | 6480464 | diallyl disulfide inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA] | CTD | PMID:24293383 |
Gclc | Rat | diallyl disulfide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | diallyl disulfide results in increased expression of GCLC mRNA | CTD | PMID:34887701 |
Gclc | Rat | diallyl disulfide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | diallyl disulfide results in increased expression of GCLC mRNA and diallyl disulfide results in increased expression of GCLC protein | CTD | PMID:34896185 and PMID:35526736 |
Gclc | Rat | diallyl disulfide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [diallyl disulfide co-treated with lipopolysaccharide more ... | CTD | PMID:34896185 |
Gclc | Rat | Diallyl sulfide | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of GCLC mRNA] and allyl sulfide inhibits the reaction [Ethylene Chlorohydrin results in increased expression of GCLC protein] | CTD | PMID:31585129 |
Gclc | Rat | Diallyl sulfide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | allyl sulfide inhibits the reaction [[ethylene dichloride co-treated with Ethanol] results in increased expression of GCLC protein] | CTD | PMID:37150348 |
Gclc | Rat | diallyl trisulfide | increases expression | EXP | | 6480464 | diallyl trisulfide results in increased expression of GCLC mRNA | CTD | PMID:34014027 |
Gclc | Rat | diallyl trisulfide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | diallyl trisulfide results in increased expression of GCLC mRNA | CTD | PMID:34887701 |
Gclc | Rat | Diallyltetrasulfane | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | diallyl tetrasulfide results in increased expression of GCLC mRNA | CTD | PMID:34887701 |
Gclc | Rat | diarsenic trioxide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC mRNA and [Arsenic Trioxide results in increased abundance of Arsenic] which results in increased expression of GCLC protein | CTD | PMID:33434570 |
Gclc | Rat | diarsenic trioxide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of GCLC mRNA | CTD | PMID:29049341 |
Gclc | Rat | diarsenic trioxide | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of GCLC protein | CTD | PMID:25341331 and PMID:25419056 |
Gclc | Rat | diarsenic trioxide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of GCLC mRNA and Arsenic Trioxide results in increased expression of GCLC protein | CTD | PMID:19417148 more ... |
Gclc | Rat | diarsenic trioxide | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 and PMID:29549912 |
Gclc | Rat | diarsenic trioxide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Arsenic Trioxide results in increased expression of GCLC mRNA] | CTD | PMID:29049341 |
Gclc | Rat | diazinon | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Diazinon results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | dibenzoylmethane | increases expression | ISO | Gclc (Mus musculus) | 6480464 | dibenzoylmethane results in increased expression of GCLC mRNA | CTD | PMID:17942926 |
Gclc | Rat | dibenzoylmethane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [sulforaphane co-treated with dibenzoylmethane] results in increased expression of GCLC mRNA | CTD | PMID:17942926 |
Gclc | Rat | Dibromoacetonitrile | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | dibromoacetonitrile results in increased expression of GCLC mRNA | CTD | PMID:35842135 |
Gclc | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of GCLC mRNA | CTD | PMID:21266533 |
Gclc | Rat | dibutyl phthalate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA | CTD | PMID:37364641 |
Gclc | Rat | Dichloroacetonitrile | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | dichloroacetonitrile results in increased expression of GCLC mRNA | CTD | PMID:35842135 |
Gclc | Rat | dichloromethane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [[Particulate Matter co-treated with Methylene Chloride] results in increased abundance of Polycyclic Aromatic Hydrocarbons] which results in decreased expression of GCLC mRNA | CTD | PMID:29335169 |
Gclc | Rat | diclofenac | decreases expression | EXP | | 6480464 | Diclofenac results in decreased expression of GCLC mRNA | CTD | PMID:17202759 |
Gclc | Rat | diclofenac | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Diclofenac affects the expression of GCLC mRNA | CTD | PMID:24752500 |
Gclc | Rat | diclofenac | affects response to substance | EXP | | 6480464 | GCLC protein affects the susceptibility to Diclofenac | CTD | PMID:19481141 |
Gclc | Rat | diethyl malate | affects expression | ISO | Gclc (Mus musculus) | 6480464 | diethyl malate affects the expression of GCLC mRNA | CTD | PMID:24814887 |
Gclc | Rat | diethyl maleate | increases expression | EXP | | 6480464 | diethyl maleate results in increased expression of GCLC mRNA and diethyl maleate results in increased expression of GCLC protein | CTD | PMID:10978506 more ... |
Gclc | Rat | diethyl maleate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | diethyl maleate results in increased expression of GCLC mRNA and diethyl maleate results in increased expression of GCLC protein | CTD | PMID:33545341 more ... |
Gclc | Rat | diethyl maleate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | diethyl maleate results in increased expression of GCLC mRNA and diethyl maleate results in increased expression of GCLC protein | CTD | PMID:10915739 and PMID:25270620 |
Gclc | Rat | diethyl maleate | increases activity | EXP | | 6480464 | diethyl maleate results in increased activity of GCLC protein | CTD | PMID:15115889 |
Gclc | Rat | diethyl maleate | increases activity | ISO | Gclc (Mus musculus) | 6480464 | diethyl maleate results in increased activity of GCLC protein | CTD | PMID:10915739 |
Gclc | Rat | diethyl phthalate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA | CTD | PMID:37364641 |
Gclc | Rat | diethyl sulfate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | diethyl sulfate results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
Gclc | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
Gclc | Rat | diethylstilbestrol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | dihydrogen | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Hydrogen inhibits the reaction [Chlorpyrifos results in decreased expression of GCLC mRNA] | CTD | PMID:32955216 |
Gclc | Rat | Diisodecyl phthalate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA | CTD | PMID:37364641 |
Gclc | Rat | diisononyl phthalate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of GCLC mRNA | CTD | PMID:37364641 |
Gclc | Rat | Dimerumic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | dimerumic acid results in increased expression of GCLC mRNA | CTD | PMID:24036144 |
Gclc | Rat | Dimerumic acid | increases activity | ISO | Gclc (Mus musculus) | 6480464 | dimerumic acid results in increased activity of GCLC protein | CTD | PMID:24036144 |
Gclc | Rat | Dimerumic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [dimerumic acid results in increased expression of GCLC mRNA] | CTD | PMID:24036144 |
Gclc | Rat | dimethyl fumarate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Dimethyl Fumarate results in increased expression of GCLC mRNA] | CTD | PMID:27277809 |
Gclc | Rat | dimethyl fumarate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Dimethyl Fumarate results in increased expression of GCLC mRNA | CTD | PMID:27277809 and PMID:30248482 |
Gclc | Rat | dimethyl fumarate | increases expression | EXP | | 6480464 | Dimethyl Fumarate results in increased expression of GCLC protein | CTD | PMID:27277809 |
Gclc | Rat | dimethylarsinic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Cacodylic Acid results in increased abundance of Arsenic] which results in increased expression of GCLC protein | CTD | PMID:33434570 |
Gclc | Rat | dinoseb | increases expression | ISO | Gclc (Mus musculus) | 6480464 | dinoseb results in increased expression of GCLC mRNA | CTD | PMID:30547568 |
Gclc | Rat | dioxygen | multiple interactions | EXP | | 6480464 | [Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC protein more ... | CTD | PMID:25773745 |
Gclc | Rat | dioxygen | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Oxygen deficiency co-treated with Catechin] results in increased expression of GCLC mRNA | CTD | PMID:35883890 |
Gclc | Rat | dioxygen | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of GCLC mRNA | CTD | PMID:35883890 |
Gclc | Rat | dioxygen | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of GCLC mRNA | CTD | PMID:25596134 and PMID:29966676 |
Gclc | Rat | dioxygen | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Oxygen deficiency co-treated with Oxygen] results in increased expression of GCLC mRNA | CTD | PMID:25922074 |
Gclc | Rat | diphenyl diselenide | multiple interactions | EXP | | 6480464 | diphenyldiselenide inhibits the reaction [Streptozocin results in decreased expression of GCLC mRNA] and diphenyldiselenide inhibits the reaction [Streptozocin results in decreased expression of GCLC protein] | CTD | PMID:33639173 |
Gclc | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Antimony Potassium Tartrate results in increased expression of GCLC mRNA and Antimony Potassium Tartrate results in increased expression of GCLC protein | CTD | PMID:28713220 |
Gclc | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA | CTD | PMID:32076005 |
Gclc | Rat | diprotium | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Hydrogen inhibits the reaction [Chlorpyrifos results in decreased expression of GCLC mRNA] | CTD | PMID:32955216 |
Gclc | Rat | diprotium oxide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GCLC mRNA | CTD | PMID:29335169 |
Gclc | Rat | diquat | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Diquat results in increased expression of GCLC mRNA | CTD | PMID:16962985 |
Gclc | Rat | diquat | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Diquat results in increased expression of GCLC protein | CTD | PMID:38128689 |
Gclc | Rat | diquat | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [KEAP1 gene mutant form inhibits the reaction [Diquat results in decreased abundance of Glutathione]] which results in increased expression of GCLC mRNA | CTD | PMID:22762311 |
Gclc | Rat | diquat | decreases activity | EXP | | 6480464 | Diquat results in decreased activity of GCLC protein | CTD | PMID:7676460 |
Gclc | Rat | diquat | decreases expression | EXP | | 6480464 | Diquat results in decreased expression of GCLC mRNA | CTD | PMID:7676460 |
Gclc | Rat | disodium selenite | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Sodium Selenite results in increased expression of GCLC mRNA | CTD | PMID:18449455 |
Gclc | Rat | disodium selenite | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of GCLC mRNA | CTD | PMID:24383545 |
Gclc | Rat | disulfiram | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Disulfiram results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of GCLC mRNA | CTD | PMID:21551480 |
Gclc | Rat | domoic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | domoic acid results in increased expression of GCLC mRNA and domoic acid results in increased expression of GCLC protein | CTD | PMID:23315585 |
Gclc | Rat | dopamine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Dopamine promotes the reaction [Zinc deficiency results in increased cleavage of GCLC protein] | CTD | PMID:23377617 |
Gclc | Rat | doramapimod | increases expression | ISO | Gclc (Mus musculus) | 6480464 | doramapimod results in increased expression of GCLC mRNA | CTD | PMID:21328587 |
Gclc | Rat | dorsomorphin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:24211276 and PMID:27188386 |
Gclc | Rat | dorsomorphin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLC mRNA | CTD | PMID:31697998 |
Gclc | Rat | doxorubicin | multiple interactions | EXP | | 6480464 | celastrol inhibits the reaction [Doxorubicin results in decreased expression of GCLC mRNA] more ... | CTD | PMID:18371937 more ... |
Gclc | Rat | doxorubicin | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of GCLC mRNA | CTD | PMID:37499777 |
Gclc | Rat | doxorubicin | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein results in decreased susceptibility to Doxorubicin | CTD | PMID:29549912 |
Gclc | Rat | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of GCLC mRNA and Doxorubicin results in decreased expression of GCLC protein | CTD | PMID:18371937 more ... |
Gclc | Rat | doxorubicin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | ABCC1 gene mutant form promotes the reaction [Doxorubicin results in increased expression of GCLC protein] and FNDC5 protein inhibits the reaction [Doxorubicin results in decreased expression of GCLC mRNA] | CTD | PMID:26822305 and PMID:37499777 |
Gclc | Rat | doxorubicin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Doxorubicin results in increased expression of GCLC protein | CTD | PMID:26822305 |
Gclc | Rat | doxorubicin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] promotes the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] and GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | CTD | PMID:10900222 and PMID:11560771 |
Gclc | Rat | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA | CTD | PMID:11444866 |
Gclc | Rat | emodin | increases expression | EXP | | 6480464 | Emodin results in increased expression of GCLC mRNA | CTD | PMID:34971761 |
Gclc | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of GCLC mRNA | CTD | PMID:29391264 |
Gclc | Rat | enzyme inhibitor | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GCLC protein | CTD | PMID:23301498 |
Gclc | Rat | epoxiconazole | increases expression | ISO | Gclc (Mus musculus) | 6480464 | epoxiconazole results in increased expression of GCLC mRNA | CTD | PMID:35436446 |
Gclc | Rat | erastin | multiple interactions | EXP | | 6480464 | NFE2L2 protein promotes the reaction [erastin results in increased expression of GCLC protein] | CTD | PMID:32937103 |
Gclc | Rat | erastin | increases expression | EXP | | 6480464 | erastin results in increased expression of GCLC protein | CTD | PMID:32937103 |
Gclc | Rat | erdosteine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | erdosteine results in increased expression of GCLC protein | CTD | PMID:26193055 |
Gclc | Rat | etacrynic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Ethacrynic Acid | CTD | PMID:10900222 |
Gclc | Rat | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of GCLC mRNA | CTD | PMID:10978506 |
Gclc | Rat | ethanol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Ethanol results in increased expression of GCLC mRNA | CTD | PMID:34995708 |
Gclc | Rat | ethanol | affects splicing | ISO | Gclc (Mus musculus) | 6480464 | Ethanol affects the splicing of GCLC mRNA | CTD | PMID:30319688 |
Gclc | Rat | ethanol | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Ethanol results in decreased expression of GCLC mRNA | CTD | PMID:27983966 |
Gclc | Rat | ethanol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [ethylene dichloride co-treated with Ethanol] results in increased expression of GCLC mRNA more ... | CTD | PMID:27983966 more ... |
Gclc | Rat | ethanol | multiple interactions | EXP | | 6480464 | [Trinitrobenzenesulfonic Acid co-treated with Ethanol] results in increased expression of GCLC mRNA | CTD | PMID:10830784 |
Gclc | Rat | ethanol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Ethanol results in increased expression of GCLC mRNA | CTD | PMID:19133322 |
Gclc | Rat | ethanol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | CYP2E1 protein promotes the reaction [Ethanol results in increased expression of GCLC mRNA] | CTD | PMID:19133322 |
Gclc | Rat | Ethyl acrylate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | ethyl acrylate results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | etoposide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] and [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Etoposide | CTD | PMID:10900222 |
Gclc | Rat | eugenol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Eugenol results in increased expression of GCLC mRNA | CTD | PMID:20566472 more ... |
Gclc | Rat | farnesal | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | farnesal results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
Gclc | Rat | farrerol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | farrerol results in increased expression of GCLC mRNA | CTD | PMID:26111761 |
Gclc | Rat | fenofibrate | decreases expression | EXP | | 6480464 | Fenofibrate results in decreased expression of GCLC mRNA | CTD | PMID:25596134 |
Gclc | Rat | fenofibrate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Fenofibrate inhibits the reaction [tyloxapol results in decreased expression of GCLC protein] | CTD | PMID:36905866 |
Gclc | Rat | fenvalerate | multiple interactions | EXP | | 6480464 | [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein | CTD | PMID:34896426 |
Gclc | Rat | ferrostatin-1 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | ferrostatin-1 inhibits the reaction [Benzene results in decreased expression of GCLC mRNA] | CTD | PMID:35661779 |
Gclc | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of GCLC mRNA | CTD | PMID:23962444 |
Gclc | Rat | flutamide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Flutamide results in increased expression of GCLC mRNA | CTD | PMID:17702527 |
Gclc | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | flutamide | affects response to substance | EXP | | 6480464 | GCLC protein affects the susceptibility to Flutamide | CTD | PMID:19481141 |
Gclc | Rat | folic acid | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Folic Acid deficiency results in decreased expression of GCLC protein | CTD | PMID:28639913 |
Gclc | Rat | folic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GCLC mRNA | CTD | PMID:22206623 |
Gclc | Rat | folpet | increases expression | ISO | Gclc (Mus musculus) | 6480464 | folpet results in increased expression of GCLC mRNA | CTD | PMID:31558096 |
Gclc | Rat | formaldehyde | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
Gclc | Rat | FR900359 | decreases phosphorylation | ISO | GCLC (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of GCLC protein | CTD | PMID:37730182 |
Gclc | Rat | fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [notoginsenoside R1 results in increased expression of GCLC protein] | CTD | PMID:24437944 |
Gclc | Rat | fumaraldehyde | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | malealdehyde results in increased expression of GCLC mRNA | CTD | PMID:35750087 |
Gclc | Rat | furan | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Bromodeoxyuridine co-treated with furan] results in increased expression of GCLC mRNA | CTD | PMID:24910943 |
Gclc | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of GCLC mRNA | CTD | PMID:27402187 |
Gclc | Rat | furan | increases expression | ISO | Gclc (Mus musculus) | 6480464 | furan results in increased expression of GCLC mRNA | CTD | PMID:24183702 and PMID:24910943 |
Gclc | Rat | galactose | decreases expression | EXP | | 6480464 | Galactose results in decreased expression of GCLC mRNA | CTD | PMID:25892055 |
Gclc | Rat | galactose | multiple interactions | EXP | | 6480464 | Saponins inhibits the reaction [Galactose results in decreased expression of GCLC mRNA] | CTD | PMID:25892055 |
Gclc | Rat | gamma-hexachlorocyclohexane | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Hexachlorocyclohexane results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | gamma-linolenic acid | increases activity | ISO | GCLC (Homo sapiens) | 6480464 | gamma-Linolenic Acid results in increased activity of GCLC protein | CTD | PMID:17092368 |
Gclc | Rat | gamma-linolenic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | gamma-Linolenic Acid results in increased expression of GCLC mRNA | CTD | PMID:17092368 |
Gclc | Rat | Gastrodin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | Gastrodin | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | gefitinib | affects response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein affects the susceptibility to gefitinib | CTD | PMID:15496427 |
Gclc | Rat | genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
Gclc | Rat | genistein | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Genistein affects the expression of GCLC mRNA | CTD | PMID:26865667 |
Gclc | Rat | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
Gclc | Rat | ginsenoside Rg1 | increases expression | ISO | Gclc (Mus musculus) | 6480464 | ginsenoside Rg1 results in increased expression of GCLC mRNA | CTD | PMID:29964319 |
Gclc | Rat | ginsenoside Rg1 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | ginsenoside Rg1 inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA] and NFE2L2 protein affects the reaction [ginsenoside Rg1 inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA]] | CTD | PMID:29964319 |
Gclc | Rat | Ginsenoside Rh4 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of GCLC mRNA] | CTD | PMID:33359794 |
Gclc | Rat | Ginsenoside Rh4 | multiple interactions | EXP | | 6480464 | ginsenoside Rh4 inhibits the reaction [Alloxan results in decreased expression of GCLC mRNA] more ... | CTD | PMID:33359794 |
Gclc | Rat | gliclazide | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA] and Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC protein] | CTD | PMID:21439372 |
Gclc | Rat | glucose | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | glucose | multiple interactions | EXP | | 6480464 | [Glucose co-treated with gastrodin] affects the expression of GCLC mRNA | CTD | PMID:33764184 |
Gclc | Rat | glutathione | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [2-tert-butylhydroquinone results in increased activity of GCLC protein] which results in increased abundance of Glutathione more ... | CTD | PMID:14978233 more ... |
Gclc | Rat | glutathione | increases expression | EXP | | 6480464 | Glutathione deficiency results in increased expression of GCLC mRNA | CTD | PMID:15345336 and PMID:20621112 |
Gclc | Rat | glutathione | affects chemical synthesis | ISO | GCLC (Homo sapiens) | 6480464 | GCLC polymorphism affects the chemical synthesis of Glutathione | CTD | PMID:16599007 |
Gclc | Rat | glutathione | increases abundance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC results in increased abundance of Glutathione | CTD | PMID:18556457 |
Gclc | Rat | glutathione | multiple interactions | EXP | | 6480464 | [HGF protein results in increased activity of GCLC protein] which results in increased chemical synthesis of Glutathione | CTD | PMID:10544272 |
Gclc | Rat | glutathione | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [[[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] which results in increased abundance of Glutathione more ... | CTD | PMID:11673643 more ... |
Gclc | Rat | glutathione | increases abundance | ISO | Gclc (Mus musculus) | 6480464 | GCLC mRNA results in increased abundance of Glutathione and GCLC protein results in increased abundance of Glutathione | CTD | PMID:19914271 more ... |
Gclc | Rat | Glutathione ethyl ester | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | S-ethyl glutathione inhibits the reaction [Hypochlorous Acid results in increased expression of GCLC mRNA] | CTD | PMID:17980396 |
Gclc | Rat | glycerol 2-phosphate | multiple interactions | EXP | | 6480464 | [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of GCLC mRNA more ... | CTD | PMID:27028516 |
Gclc | Rat | guggulsterone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | pregna-4 more ... | CTD | PMID:22851183 |
Gclc | Rat | guggulsterone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | pregna-4 more ... | CTD | PMID:22851183 |
Gclc | Rat | hemin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Hemin results in increased expression of GCLC mRNA and Hemin results in increased expression of GCLC protein | CTD | PMID:16631525 and PMID:33434570 |
Gclc | Rat | hemin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Hemin] results in increased expression of GCLC mRNA and [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Hemin] results in increased expression of GCLC protein | CTD | PMID:33434570 |
Gclc | Rat | Hexachloro-1,3-butadiene | decreases expression | EXP | | 6480464 | hexachlorobutadiene results in decreased expression of GCLC mRNA | CTD | PMID:21905055 |
Gclc | Rat | Hexachloro-1,3-butadiene | increases expression | EXP | | 6480464 | hexachlorobutadiene results in increased expression of GCLC mRNA | CTD | PMID:21905055 |
Gclc | Rat | hexadecanoic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of GCLC mRNA | CTD | PMID:28027979 |
Gclc | Rat | hexadecanoic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLC protein and Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLC protein] | CTD | PMID:36905866 |
Gclc | Rat | hexane | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | n-hexane results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | hydrogen chloride | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 gene mutant form inhibits the reaction [Hydrochloric Acid results in increased expression of GCLC mRNA] | CTD | PMID:29618784 |
Gclc | Rat | hydrogen chloride | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Hydrochloric Acid results in increased expression of GCLC mRNA | CTD | PMID:29618784 |
Gclc | Rat | hydrogen peroxide | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of GCLC mRNA | CTD | PMID:20044591 |
Gclc | Rat | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of GCLC mRNA and Hydrogen Peroxide results in decreased expression of GCLC protein | CTD | PMID:36305173 |
Gclc | Rat | hydrogen peroxide | multiple interactions | EXP | | 6480464 | Hydrogen Peroxide affects the reaction [[beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of GCLC mRNA] more ... | CTD | PMID:24437944 and PMID:27028516 |
Gclc | Rat | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of GCLC protein | CTD | PMID:24437944 |
Gclc | Rat | hydrogen peroxide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 4-((alpha-L-rhamnosyloxy)benzyl)isothiocyanate inhibits the reaction [Hydrogen Peroxide results in decreased expression of GCLC mRNA] more ... | CTD | PMID:24866057 and PMID:31521693 |
Gclc | Rat | hydrogen peroxide | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Hydrogen Peroxide results in decreased expression of GCLC mRNA and Hydrogen Peroxide results in decreased expression of GCLC protein | CTD | PMID:24866057 and PMID:31521693 |
Gclc | Rat | hydrogen peroxide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of GCLC mRNA | CTD | PMID:12598062 more ... |
Gclc | Rat | hydrogen peroxide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | GCLC protein inhibits the reaction [Hydrogen Peroxide results in decreased abundance of Glutathione] more ... | CTD | PMID:19914271 and PMID:31494107 |
Gclc | Rat | hydrogen peroxide | decreases response to substance | ISO | Gclc (Mus musculus) | 6480464 | GCLC protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:19914271 |
Gclc | Rat | hydroquinone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | hydroquinone results in increased expression of GCLC mRNA and hydroquinone results in increased expression of GCLC protein | CTD | PMID:23290930 and PMID:30547568 |
Gclc | Rat | hydroquinone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | hydroquinone results in increased expression of GCLC mRNA | CTD | PMID:23940045 and PMID:32334435 |
Gclc | Rat | hydroquinone | affects methylation | ISO | GCLC (Homo sapiens) | 6480464 | hydroquinone affects the methylation of GCLC promoter | CTD | PMID:23940045 |
Gclc | Rat | hydroquinone | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [hydroquinone affects the methylation of GCLC promoter] which results in decreased abundance of 5-Methylcytosine more ... | CTD | PMID:23940045 and PMID:32334435 |
Gclc | Rat | hypochlorous acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of GCLC mRNA] more ... | CTD | PMID:17980396 |
Gclc | Rat | hypochlorous acid | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Hypochlorous Acid affects the expression of GCLC mRNA | CTD | PMID:18648578 |
Gclc | Rat | hypochlorous acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of GCLC mRNA | CTD | PMID:17980396 |
Gclc | Rat | ibuprofen | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Ibuprofen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
Gclc | Rat | ifosfamide | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Ifosfamide results in decreased expression of GCLC mRNA | CTD | PMID:25596134 |
Gclc | Rat | indometacin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Indomethacin results in increased expression of GCLC mRNA] more ... | CTD | PMID:11909699 |
Gclc | Rat | indometacin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Rosiglitazone co-treated with Indomethacin] results in increased expression of GCLC mRNA | CTD | PMID:33412187 |
Gclc | Rat | indometacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of GCLC mRNA | CTD | PMID:36868495 |
Gclc | Rat | indometacin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Indomethacin results in increased expression of GCLC mRNA and Indomethacin results in increased expression of GCLC protein | CTD | PMID:11820781 and PMID:11909699 |
Gclc | Rat | iron atom | increases activity | EXP | | 6480464 | Iron results in increased activity of GCLC protein | CTD | PMID:17189828 |
Gclc | Rat | iron atom | decreases expression | EXP | | 6480464 | Iron results in decreased expression of GCLC protein | CTD | PMID:35247364 |
Gclc | Rat | iron atom | multiple interactions | EXP | | 6480464 | leonurine inhibits the reaction [Iron results in decreased expression of GCLC protein] | CTD | PMID:35247364 |
Gclc | Rat | iron atom | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Iron results in decreased expression of GCLC mRNA | CTD | PMID:19073151 |
Gclc | Rat | iron atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLC mRNA] | CTD | PMID:19073151 |
Gclc | Rat | iron trichloride | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [ferric chloride co-treated with TNF protein] results in increased expression of GCLC protein | CTD | PMID:19900513 |
Gclc | Rat | iron(0) | increases activity | EXP | | 6480464 | Iron results in increased activity of GCLC protein | CTD | PMID:17189828 |
Gclc | Rat | iron(0) | multiple interactions | EXP | | 6480464 | leonurine inhibits the reaction [Iron results in decreased expression of GCLC protein] | CTD | PMID:35247364 |
Gclc | Rat | iron(0) | decreases expression | EXP | | 6480464 | Iron results in decreased expression of GCLC protein | CTD | PMID:35247364 |
Gclc | Rat | iron(0) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLC mRNA] | CTD | PMID:19073151 |
Gclc | Rat | iron(0) | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Iron results in decreased expression of GCLC mRNA | CTD | PMID:19073151 |
Gclc | Rat | iron(2+) sulfate (anhydrous) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | ferrous sulfate promotes the reaction [SNCA protein results in decreased expression of GCLC protein] | CTD | PMID:27424009 |
Gclc | Rat | iron(2+) sulfate (anhydrous) | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | ferrous sulfate results in decreased expression of GCLC protein | CTD | PMID:27424009 |
Gclc | Rat | iron(III) nitrilotriacetate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | ferric nitrilotriacetate results in increased expression of GCLC mRNA | CTD | PMID:18617210 |
Gclc | Rat | isoeugenol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | isoeugenol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | isoniazide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Isoniazid results in increased expression of GCLC mRNA | CTD | PMID:33771660 |
Gclc | Rat | isoniazide | multiple interactions | EXP | | 6480464 | chrysin inhibits the reaction [Isoniazid results in increased expression of GCLC mRNA] | CTD | PMID:33121995 |
Gclc | Rat | isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of GCLC mRNA | CTD | PMID:33121995 |
Gclc | Rat | isoniazide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Isoniazid inhibits the reaction [2-tert-butylhydroquinone results in increased expression of GCLC mRNA] | CTD | PMID:24128855 |
Gclc | Rat | isoniazide | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Isoniazid results in decreased expression of GCLC mRNA | CTD | PMID:24128855 |
Gclc | Rat | isoprenaline | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Isoproterenol results in decreased expression of GCLC mRNA | CTD | PMID:21335049 |
Gclc | Rat | isorhamnetin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] more ... | CTD | PMID:24211276 |
Gclc | Rat | isorhamnetin | multiple interactions | EXP | | 6480464 | [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC mRNA and [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC protein | CTD | PMID:25716194 |
Gclc | Rat | isorhamnetin | increases expression | EXP | | 6480464 | 3-methylquercetin results in increased expression of GCLC mRNA and 3-methylquercetin results in increased expression of GCLC protein | CTD | PMID:25716194 |
Gclc | Rat | isorhamnetin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | CTD | PMID:24211276 |
Gclc | Rat | isothiocyanate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Isothiocyanates results in increased expression of GCLC protein | CTD | PMID:15570060 |
Gclc | Rat | ivermectin | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of GCLC protein | CTD | PMID:32959892 |
Gclc | Rat | kaempferol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | kaempferol results in increased expression of GCLC mRNA | CTD | PMID:11864778 |
Gclc | Rat | kaempferol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | kaempferol affects the reaction [propacetamol affects the expression of GCLC protein] | CTD | PMID:29574133 |
Gclc | Rat | kahweol | multiple interactions | EXP | | 6480464 | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GCLC protein] | CTD | PMID:17110534 |
Gclc | Rat | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of GCLC mRNA | CTD | PMID:20080153 |
Gclc | Rat | ketamine | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [Ketamine results in decreased expression of GCLC mRNA] and Curcumin inhibits the reaction [Ketamine results in decreased expression of GCLC protein] | CTD | PMID:36305173 |
Gclc | Rat | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of GCLC mRNA and Ketamine results in decreased expression of GCLC protein | CTD | PMID:36305173 |
Gclc | Rat | ketoprofen | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Ketoprofen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
Gclc | Rat | L-ascorbic acid | multiple interactions | EXP | | 6480464 | [beta-glycerophosphoric acid co-treated with Ascorbic Acid co-treated with Dexamethasone] affects the expression of GCLC mRNA more ... | CTD | PMID:27028516 and PMID:31585129 |
Gclc | Rat | L-ascorbic acid 2-phosphate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLC mRNA | CTD | PMID:34480604 |
Gclc | Rat | L-cysteine | multiple interactions | EXP | | 6480464 | Cysteine promotes the reaction [GCLC protein results in increased chemical synthesis of gamma-glutamylcysteine] | CTD | PMID:15115889 |
Gclc | Rat | L-gamma-glutamyl-L-cysteine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC protein results in increased chemical synthesis of gamma-glutamylcysteine] more ... | CTD | PMID:15115889 |
Gclc | Rat | L-gamma-glutamyl-L-cysteine | increases chemical synthesis | EXP | | 6480464 | GCLC protein results in increased chemical synthesis of gamma-glutamylcysteine | CTD | PMID:15115889 |
Gclc | Rat | L-methionine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA and NFE2L2 affects the reaction [[Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA] | CTD | PMID:20350562 |
Gclc | Rat | lanthanum trichloride | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | lanthanum chloride results in decreased expression of GCLC protein | CTD | PMID:33098623 |
Gclc | Rat | lanthanum trichloride | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [cerous chloride co-treated with lanthanum chloride] results in increased expression of GCLC mRNA | CTD | PMID:28954213 |
Gclc | Rat | lanthanum trichloride | increases expression | ISO | Gclc (Mus musculus) | 6480464 | lanthanum chloride results in increased expression of GCLC mRNA and lanthanum chloride results in increased expression of GCLC protein | CTD | PMID:24142884 |
Gclc | Rat | lead diacetate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [lead acetate results in increased expression of GCLC mRNA] | CTD | PMID:26498409 |
Gclc | Rat | lead diacetate | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of GCLC mRNA | CTD | PMID:39276841 |
Gclc | Rat | lead diacetate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | lead acetate results in increased expression of GCLC mRNA | CTD | PMID:26498409 and PMID:38568856 |
Gclc | Rat | lead(0) | multiple interactions | EXP | | 6480464 | [lead acetate results in increased abundance of Lead] which results in increased expression of GCLC mRNA | CTD | PMID:39276841 |
Gclc | Rat | lead(II) chloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | lead chloride results in increased expression of GCLC mRNA | CTD | PMID:18654764 |
Gclc | Rat | lead(II) chloride | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | lead chloride results in decreased expression of GCLC protein | CTD | PMID:30359721 |
Gclc | Rat | lead(II) chloride | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GCLC mRNA | CTD | PMID:18654764 |
Gclc | Rat | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | Leonurine | multiple interactions | EXP | | 6480464 | leonurine inhibits the reaction [Iron results in decreased expression of GCLC protein] | CTD | PMID:35247364 |
Gclc | Rat | levofloxacin | decreases expression | EXP | | 6480464 | Levofloxacin results in decreased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | linalool | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | linalool results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
Gclc | Rat | lipoic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Thioctic Acid results in increased expression of GCLC mRNA | CTD | PMID:16249512 more ... |
Gclc | Rat | lipoic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Thioctic Acid promotes the reaction [Cadmium Chloride results in increased expression of GCLC mRNA] and Thioctic Acid results in increased expression of and results in increased activity of GCLC protein | CTD | PMID:26365678 |
Gclc | Rat | lipoic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Thioctic Acid inhibits the reaction [Silicon results in decreased expression of GCLC protein] | CTD | PMID:34252510 |
Gclc | Rat | lipoic acid | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [methylmercuric chloride results in decreased expression of GCLC protein] more ... | CTD | PMID:27298056 and PMID:32061141 |
Gclc | Rat | lipopolysaccharide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 8-oxoberberine promotes the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of GCLC mRNA] more ... | CTD | PMID:35691465 |
Gclc | Rat | liquiritigenin | increases expression | EXP | | 6480464 | liquiritigenin results in increased expression of GCLC protein | CTD | PMID:29908794 |
Gclc | Rat | liquiritigenin | multiple interactions | EXP | | 6480464 | liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GCLC mRNA] | CTD | PMID:29908794 |
Gclc | Rat | liquiritin | increases expression | EXP | | 6480464 | liquiritin results in increased expression of GCLC protein | CTD | PMID:29908794 |
Gclc | Rat | liquiritin | multiple interactions | EXP | | 6480464 | liquiritin inhibits the reaction [Monocrotaline results in decreased expression of GCLC mRNA] | CTD | PMID:29908794 |
Gclc | Rat | lithocholic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Lithocholic Acid results in increased expression of GCLC mRNA and Lithocholic Acid results in increased expression of GCLC protein | CTD | PMID:20977460 |
Gclc | Rat | lithocholic acid | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Lithocholic Acid results in decreased expression of GCLC mRNA | CTD | PMID:29794447 |
Gclc | Rat | lithocholic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Lithocholic Acid results in increased expression of GCLC protein | CTD | PMID:17724089 |
Gclc | Rat | lithocholic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA more ... | CTD | PMID:17724089 and PMID:20146260 |
Gclc | Rat | lithocholic acid | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Lithocholic Acid affects the expression of GCLC mRNA and Lithocholic Acid affects the expression of GCLC protein | CTD | PMID:20146260 |
Gclc | Rat | lithocholic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Lithocholic Acid results in increased activity of NFE2L2 protein] which results in increased expression of GCLC mRNA more ... | CTD | PMID:17724089 more ... |
Gclc | Rat | luteolin | increases expression | EXP | | 6480464 | Luteolin results in increased expression of GCLC mRNA and Luteolin results in increased expression of GCLC protein | CTD | PMID:22864849 |
Gclc | Rat | luteolin | multiple interactions | EXP | | 6480464 | [Luteolin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:22864849 |
Gclc | Rat | Luteolin 7-methyl ether | increases expression | EXP | | 6480464 | hydroxygenkwanin results in increased expression of GCLC mRNA | CTD | PMID:38942164 |
Gclc | Rat | LY294002 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cinnamaldehyde results in increased expression of GCLC protein] more ... | CTD | PMID:19073151 more ... |
Gclc | Rat | LY294002 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLC mRNA]] | CTD | PMID:25895139 |
Gclc | Rat | LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of GCLC protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts results in increased expression of GCLC mRNA] | CTD | PMID:20399244 and PMID:25773745 |
Gclc | Rat | LY294002 | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GCLC mRNA | CTD | PMID:19073151 |
Gclc | Rat | lycopene | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Lycopene inhibits the reaction [Atrazine results in increased expression of GCLC mRNA] and Lycopene inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GCLC mRNA] | CTD | PMID:35917956 more ... |
Gclc | Rat | maneb | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of GCLC mRNA | CTD | PMID:21402726 |
Gclc | Rat | maneb | increases activity | EXP | | 6480464 | Maneb results in increased activity of GCLC protein | CTD | PMID:15527874 |
Gclc | Rat | melatonin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 4-phenyl-2-propionamidotetraline inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLC mRNA]] more ... | CTD | PMID:25550330 |
Gclc | Rat | meloxicam | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | meloxicam inhibits the reaction [Paraquat results in decreased expression of GCLC protein] | CTD | PMID:20851755 |
Gclc | Rat | menadione | increases activity | ISO | GCLC (Homo sapiens) | 6480464 | Vitamin K 3 results in increased activity of GCLC protein | CTD | PMID:11972604 |
Gclc | Rat | menadione | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Vitamin K 3 results in increased expression of GCLC mRNA | CTD | PMID:11972604 and PMID:23410634 |
Gclc | Rat | menadione | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Vitamin K 3 results in increased expression of GCLC mRNA | CTD | PMID:25270620 |
Gclc | Rat | menadione | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA] | CTD | PMID:11972604 |
Gclc | Rat | mercury atom | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Mercury results in increased expression of GCLC mRNA | CTD | PMID:17547211 |
Gclc | Rat | mercury atom | multiple interactions | EXP | | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GCLC mRNA more ... | CTD | PMID:27837179 |
Gclc | Rat | mercury atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of GCLC protein and GCLC gene polymorphism promotes the reaction [GSTP1 gene polymorphism affects the abundance of Mercury] | CTD | PMID:19515364 and PMID:30359721 |
Gclc | Rat | mercury atom | affects response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC gene SNP affects the susceptibility to Mercury | CTD | PMID:22236634 |
Gclc | Rat | mercury dibromide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of GCLC mRNA | CTD | PMID:26272509 |
Gclc | Rat | mercury dibromide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLC mRNA | CTD | PMID:27188386 |
Gclc | Rat | mercury dichloride | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein results in decreased susceptibility to Mercuric Chloride | CTD | PMID:24118919 |
Gclc | Rat | mercury dichloride | multiple interactions | EXP | | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GCLC mRNA more ... | CTD | PMID:27837179 |
Gclc | Rat | mercury dichloride | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of GCLC protein | CTD | PMID:30359721 |
Gclc | Rat | mercury dichloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Mercuric Chloride results in increased expression of GCLC mRNA | CTD | PMID:24118919 and PMID:38568856 |
Gclc | Rat | mercury(0) | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Mercury results in increased expression of GCLC mRNA | CTD | PMID:17547211 |
Gclc | Rat | mercury(0) | multiple interactions | EXP | | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in increased expression of GCLC mRNA more ... | CTD | PMID:27837179 |
Gclc | Rat | mercury(0) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Mercuric Chloride results in increased abundance of Mercury] which results in decreased expression of GCLC protein and GCLC gene polymorphism promotes the reaction [GSTP1 gene polymorphism affects the abundance of Mercury] | CTD | PMID:19515364 and PMID:30359721 |
Gclc | Rat | mercury(0) | affects response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC gene SNP affects the susceptibility to Mercury | CTD | PMID:22236634 |
Gclc | Rat | mesalamine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased expression of GCLC mRNA | CTD | PMID:27818126 |
Gclc | Rat | metformin | increases expression | EXP | | 6480464 | Metformin results in increased expression of GCLC mRNA | CTD | PMID:25596134 |
Gclc | Rat | methapyrilene | increases expression | EXP | | 6480464 | Methapyrilene results in increased expression of GCLC mRNA and Methapyrilene results in increased expression of GCLC protein | CTD | PMID:15890375 more ... |
Gclc | Rat | methimazole | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Methimazole results in increased expression of GCLC mRNA | CTD | PMID:20144635 |
Gclc | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of GCLC mRNA | CTD | PMID:30047161 |
Gclc | Rat | methotrexate | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Methotrexate affects the expression of GCLC mRNA | CTD | PMID:18502557 |
Gclc | Rat | methoxychlor | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
Gclc | Rat | methoxychlor | increases expression | EXP | | 6480464 | Methoxychlor results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
Gclc | Rat | methyl non-2-ynoate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-nonynoic acid methyl ester results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
Gclc | Rat | methyl salicylate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | methyl salicylate results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | methylene blue | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Methylene Blue co-treated with MAPT protein mutant form] results in increased expression of GCLC mRNA and NFE2L2 gene mutant form inhibits the reaction [Methylene Blue results in increased expression of GCLC mRNA] | CTD | PMID:24556215 |
Gclc | Rat | methylene blue | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Methylene Blue results in increased expression of GCLC mRNA | CTD | PMID:24556215 |
Gclc | Rat | methylisothiazolinone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of GCLC mRNA | CTD | PMID:30806763 |
Gclc | Rat | methylmercury chloride | increases expression | ISO | Gclc (Mus musculus) | 6480464 | methylmercuric chloride results in increased expression of GCLC mRNA | CTD | PMID:20061341 |
Gclc | Rat | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of GCLC protein | CTD | PMID:32061141 |
Gclc | Rat | methylmercury chloride | multiple interactions | EXP | | 6480464 | Thioctic Acid inhibits the reaction [methylmercuric chloride results in decreased expression of GCLC protein] more ... | CTD | PMID:27298056 and PMID:32061141 |
Gclc | Rat | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of GCLC mRNA and methylmercuric chloride results in increased expression of GCLC protein | CTD | PMID:27298056 and PMID:32061141 |
Gclc | Rat | methylmercury chloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of GCLC mRNA | CTD | PMID:24118919 and PMID:28001369 |
Gclc | Rat | methylmercury chloride | decreases response to substance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC protein results in decreased susceptibility to methylmercuric chloride | CTD | PMID:24118919 |
Gclc | Rat | Methysticin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | methysticin results in increased expression of GCLC mRNA | CTD | PMID:28448946 |
Gclc | Rat | microcystin | increases expression | EXP | | 6480464 | Microcystins analog results in increased expression of GCLC mRNA | CTD | PMID:24964298 |
Gclc | Rat | microcystin | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [Microcystins analog results in increased expression of GCLC mRNA] | CTD | PMID:24964298 |
Gclc | Rat | microcystin-LR | increases expression | ISO | Gclc (Mus musculus) | 6480464 | cyanoginosin LR results in increased expression of GCLC mRNA | CTD | PMID:17654400 |
Gclc | Rat | microcystin-LR | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | cyanoginosin LR results in decreased expression of and results in increased phosphorylation of GCLC protein and GCLC protein inhibits the reaction [cyanoginosin LR results in decreased activity of CAT protein] | CTD | PMID:30940545 |
Gclc | Rat | microcystin-LR | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | cyanoginosin LR results in decreased expression of GCLC mRNA | CTD | PMID:30940545 |
Gclc | Rat | mifepristone | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]] and Mifepristone results in increased activity of [GCLC protein binds to GCLM protein] | CTD | PMID:16840778 |
Gclc | Rat | mifepristone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Mifepristone results in increased expression of GCLC protein | CTD | PMID:16840778 |
Gclc | Rat | miquelianin | multiple interactions | EXP | | 6480464 | [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC mRNA and [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC protein | CTD | PMID:25716194 |
Gclc | Rat | MK 571 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [verlukast binds to and results in decreased activity of ABCC1 protein] inhibits the reaction [15-deoxy-delta(12 and 14)-prostaglandin J2 results in increased expression of GCLC protein] | CTD | PMID:21728338 |
Gclc | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of GCLC mRNA | CTD | PMID:34863575 |
Gclc | Rat | monocrotaline | multiple interactions | EXP | | 6480464 | liquiritigenin inhibits the reaction [Monocrotaline results in decreased expression of GCLC mRNA] and liquiritin inhibits the reaction [Monocrotaline results in decreased expression of GCLC mRNA] | CTD | PMID:29908794 |
Gclc | Rat | monocrotaline | decreases expression | EXP | | 6480464 | Monocrotaline results in decreased expression of GCLC mRNA | CTD | PMID:29908794 |
Gclc | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GCLC mRNA | CTD | PMID:28659758 |
Gclc | Rat | N,N-dimethylformamide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Dimethylformamide results in increased expression of GCLC protein | CTD | PMID:37995826 |
Gclc | Rat | N,N-dimethylformamide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | allyl methyl disulfide inhibits the reaction [Dimethylformamide results in increased expression of GCLC protein] | CTD | PMID:37995826 |
Gclc | Rat | N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | N-(3 and 5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of GCLC mRNA] | CTD | PMID:19747488 |
Gclc | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [15-deoxy-delta(12 more ... | CTD | PMID:11820781 more ... |
Gclc | Rat | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [decamethrin results in increased expression of GCLC mRNA] and Acetylcysteine inhibits the reaction [decamethrin results in increased expression of GCLC protein] | CTD | PMID:17540521 |
Gclc | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [2' more ... | CTD | PMID:17980396 more ... |
Gclc | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GCLC mRNA and benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GCLC protein | CTD | PMID:30186748 and PMID:33434570 |
Gclc | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [benzyloxycarbonylleucyl-leucyl-leucine aldehyde co-treated with Hemin] results in increased expression of GCLC mRNA more ... | CTD | PMID:25263748 more ... |
Gclc | Rat | N-methyl-4-phenylpyridinium | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC mRNA and [1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC protein | CTD | PMID:32763437 |
Gclc | Rat | N-methyl-4-phenylpyridinium | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC mRNA more ... | CTD | PMID:32763437 |
Gclc | Rat | N-methylformamide | affects expression | ISO | Gclc (Mus musculus) | 6480464 | methylformamide affects the expression of GCLC mRNA and methylformamide analog affects the expression of GCLC mRNA | CTD | PMID:17040096 |
Gclc | Rat | N-methylnicotinate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | trigonelline inhibits the reaction [Pyocyanine results in increased expression of GCLC mRNA] | CTD | PMID:24015256 |
Gclc | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLC mRNA more ... | CTD | PMID:14656948 more ... |
Gclc | Rat | N-nitrosodiethylamine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:35523338 |
Gclc | Rat | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:19638242 |
Gclc | Rat | N-nitrosodimethylamine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Dimethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:17547211 |
Gclc | Rat | N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of GCLC protein | CTD | PMID:23485615 |
Gclc | Rat | N-nitrosodimethylamine | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Dimethylnitrosamine results in decreased expression of GCLC protein] | CTD | PMID:23485615 |
Gclc | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:14600272 and PMID:15890375 |
Gclc | Rat | N-tosyl-L-phenylalanyl chloromethyl ketone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLC mRNA | CTD | PMID:22851183 |
Gclc | Rat | N-tosyl-L-phenylalanyl chloromethyl ketone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLC mRNA | CTD | PMID:22851183 |
Gclc | Rat | naphthalene | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC protein results in decreased susceptibility to naphthalene] more ... | CTD | PMID:10900227 and PMID:12805647 |
Gclc | Rat | naphthalene | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | naphthalene results in decreased expression of GCLC mRNA | CTD | PMID:31020322 |
Gclc | Rat | naphthalene | increases expression | EXP | | 6480464 | naphthalene analog results in increased expression of GCLC mRNA and naphthalene results in increased expression of GCLC mRNA | CTD | PMID:24563378 and PMID:24976557 |
Gclc | Rat | naphthalene | increases activity | ISO | Gclc (Mus musculus) | 6480464 | naphthalene results in increased activity of GCLC protein | CTD | PMID:10900227 |
Gclc | Rat | naphthalene | decreases response to substance | ISO | Gclc (Mus musculus) | 6480464 | GCLC protein results in decreased susceptibility to naphthalene | CTD | PMID:10900227 and PMID:12805647 |
Gclc | Rat | naphthalene-1,2-diol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 1 and 2-dihydroxynaphthalene analog results in increased expression of GCLC mRNA | CTD | PMID:25807370 |
Gclc | Rat | naproxen | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Naproxen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
Gclc | Rat | naringin | multiple interactions | EXP | | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringin results in increased expression of GCLC protein] more ... | CTD | PMID:22871521 and PMID:25773745 |
Gclc | Rat | naringin | increases expression | EXP | | 6480464 | naringin results in increased expression of GCLC mRNA and naringin results in increased expression of GCLC protein | CTD | PMID:22871521 and PMID:25773745 |
Gclc | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | neoastilbin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | astilbin inhibits the reaction [Cisplatin results in decreased expression of GCLC mRNA] | CTD | PMID:29471006 |
Gclc | Rat | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of GCLC mRNA | CTD | PMID:22110744 |
Gclc | Rat | nickel dichloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | nickel chloride results in increased expression of GCLC mRNA | CTD | PMID:17547211 and PMID:21111804 |
Gclc | Rat | nickel sulfate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | nickel sulfate results in increased expression of GCLC mRNA | CTD | PMID:16100012 |
Gclc | Rat | nickel sulfate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of GCLC mRNA | CTD | PMID:20491607 and PMID:20566472 |
Gclc | Rat | nicotinamide | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA more ... | CTD | PMID:21439372 |
Gclc | Rat | nicotine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1 more ... | CTD | PMID:20230807 |
Gclc | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | nimustine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Nimustine results in increased expression of GCLC mRNA | CTD | PMID:9393752 |
Gclc | Rat | nitisinone | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [nitisinone results in decreased activity of HPD protein] which results in decreased expression of GCLC mRNA | CTD | PMID:12899938 |
Gclc | Rat | nitric oxide | decreases expression | EXP | | 6480464 | Nitric Oxide deficiency results in decreased expression of GCLC mRNA and Nitric Oxide deficiency results in decreased expression of GCLC protein | CTD | PMID:19631198 |
Gclc | Rat | nitrofurantoin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Nitrofurantoin results in increased expression of GCLC protein] and POR protein affects the reaction [Nitrofurantoin results in increased expression of GCLC protein] | CTD | PMID:34021431 |
Gclc | Rat | nitrofurantoin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Nitrofurantoin results in increased expression of GCLC protein | CTD | PMID:34021431 |
Gclc | Rat | Nodularin | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | nodularin affects the expression of GCLC mRNA | CTD | PMID:30562542 |
Gclc | Rat | Nonidet P-40 | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Nonidet P-40 results in decreased expression of GCLC mRNA | CTD | PMID:26552463 |
Gclc | Rat | norswertianolin | increases expression | EXP | | 6480464 | norswertianolin results in increased expression of GCLC mRNA and norswertianolin results in increased expression of GCLC protein | CTD | PMID:30800665 |
Gclc | Rat | notoginsenoside R1 | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [notoginsenoside R1 results in increased expression of GCLC protein] more ... | CTD | PMID:24437944 |
Gclc | Rat | notoginsenoside R1 | increases expression | EXP | | 6480464 | notoginsenoside R1 results in increased expression of GCLC protein | CTD | PMID:24437944 |
Gclc | Rat | Nutlin-3 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of GCLC protein | CTD | PMID:38460933 |
Gclc | Rat | ochratoxin A | multiple interactions | EXP | | 6480464 | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GCLC protein] | CTD | PMID:17110534 |
Gclc | Rat | ochratoxin A | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | ochratoxin A results in increased expression of GCLC mRNA | CTD | PMID:30291945 and PMID:32905824 |
Gclc | Rat | ochratoxin A | increases expression | ISO | Gclc (Mus musculus) | 6480464 | ochratoxin A results in increased expression of GCLC mRNA | CTD | PMID:30291945 |
Gclc | Rat | ochratoxin A | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | AHR protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA] and NR1I2 protein affects the reaction [ochratoxin A results in increased expression of GCLC mRNA] | CTD | PMID:30291945 |
Gclc | Rat | ochratoxin A | affects expression | EXP | | 6480464 | ochratoxin A affects the expression of GCLC mRNA | CTD | PMID:32468156 |
Gclc | Rat | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of GCLC mRNA and ochratoxin A results in decreased expression of GCLC protein | CTD | PMID:16251485 more ... |
Gclc | Rat | olanzapine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Olanzapine results in increased expression of GCLC mRNA | CTD | PMID:37005277 |
Gclc | Rat | oleanolic acid | increases expression | EXP | | 6480464 | Oleanolic Acid results in increased expression of GCLC mRNA | CTD | PMID:18706400 |
Gclc | Rat | oleanolic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Oleanolic Acid results in increased expression of GCLC mRNA and Oleanolic Acid results in increased expression of GCLC protein | CTD | PMID:18706400 more ... |
Gclc | Rat | oleic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLC protein and Escin inhibits the reaction [[Palmitic Acid co-treated with Oleic Acid] results in decreased expression of GCLC protein] | CTD | PMID:36905866 |
Gclc | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCLC mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of GCLC mRNA | CTD | PMID:25729387 |
Gclc | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of GCLC mRNA | CTD | PMID:25729387 |
Gclc | Rat | oxidopamine | increases expression | EXP | | 6480464 | Oxidopamine results in increased expression of GCLC mRNA and Oxidopamine results in increased expression of GCLC protein | CTD | PMID:21397656 |
Gclc | Rat | oxidopamine | multiple interactions | EXP | | 6480464 | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLC protein] | CTD | PMID:25446857 |
Gclc | Rat | oxidopamine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | salvin inhibits the reaction [Oxidopamine results in decreased expression of GCLC protein] | CTD | PMID:25446857 |
Gclc | Rat | oxidopamine | decreases expression | EXP | | 6480464 | Oxidopamine results in decreased expression of GCLC protein | CTD | PMID:25446857 |
Gclc | Rat | oxidopamine | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Oxidopamine results in decreased expression of GCLC protein | CTD | PMID:25446857 |
Gclc | Rat | ozone | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of GCLC mRNA more ... | CTD | PMID:17460151 more ... |
Gclc | Rat | ozone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Ozone results in increased expression of GCLC mRNA | CTD | PMID:17095637 |
Gclc | Rat | p-chloromercuribenzoic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of GCLC mRNA | CTD | PMID:26272509 |
Gclc | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLC mRNA | CTD | PMID:27188386 |
Gclc | Rat | para-Cresidine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | cresidine results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | paracetamol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Chlorogenic Acid promotes the reaction [Acetaminophen results in increased expression of GCLC mRNA] more ... | CTD | PMID:25881548 and PMID:29136249 |
Gclc | Rat | paracetamol | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of GCLC mRNA | CTD | PMID:25818464 and PMID:29355602 |
Gclc | Rat | paracetamol | decreases response to substance | ISO | Gclc (Mus musculus) | 6480464 | GCLC protein results in decreased susceptibility to Acetaminophen | CTD | PMID:18642143 and PMID:24661219 |
Gclc | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GCLC mRNA | CTD | PMID:26767949 |
Gclc | Rat | paracetamol | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of GCLC mRNA and Acetaminophen results in decreased expression of GCLC protein | CTD | PMID:27761495 and PMID:37792503 |
Gclc | Rat | paracetamol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Acetaminophen results in increased expression of GCLC mRNA and Acetaminophen results in increased expression of GCLC protein | CTD | PMID:10915739 more ... |
Gclc | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:11245408 more ... |
Gclc | Rat | paracetamol | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Acetaminophen affects the expression of GCLC mRNA | CTD | PMID:15606129 more ... |
Gclc | Rat | paracetamol | affects response to substance | EXP | | 6480464 | GCLC protein affects the susceptibility to Acetaminophen | CTD | PMID:17573345 |
Gclc | Rat | paracetamol | decreases activity | ISO | Gclc (Mus musculus) | 6480464 | Acetaminophen results in decreased activity of GCLC protein | CTD | PMID:10915739 |
Gclc | Rat | paracetamol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Acetaminophen co-treated with amlexanox co-treated with dorsomorphin] affects the expression of GCLC mRNA more ... | CTD | PMID:15122755 more ... |
Gclc | Rat | paracetamol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:21420995 more ... |
Gclc | Rat | paraquat | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Paraquat results in increased expression of GCLC mRNA | CTD | PMID:17215068 and PMID:31216030 |
Gclc | Rat | paraquat | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | SIRT6 promotes the reaction [Paraquat results in increased expression of GCLC mRNA] | CTD | PMID:31216030 |
Gclc | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of GCLC mRNA | CTD | PMID:26598004 more ... |
Gclc | Rat | paraquat | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Paraquat results in decreased expression of GCLC mRNA and Paraquat results in decreased expression of GCLC protein | CTD | PMID:20851755 and PMID:24866057 |
Gclc | Rat | paraquat | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLC mRNA more ... | CTD | PMID:20851755 more ... |
Gclc | Rat | paraquat | affects expression | EXP | | 6480464 | Paraquat affects the expression of GCLC mRNA | CTD | PMID:16854511 |
Gclc | Rat | perfluorobutyric acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | perfluorobutyric acid results in increased expression of GCLC mRNA | CTD | PMID:34474067 |
Gclc | Rat | perfluorohexanesulfonic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [perfluorohexanesulfonic acid co-treated with Dietary Fats co-treated with Dietary Carbohydrates] results in increased expression of GCLC mRNA | CTD | PMID:32991729 |
Gclc | Rat | perfluorononanoic acid | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of GCLC mRNA | CTD | PMID:23567314 |
Gclc | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of GCLC mRNA | CTD | PMID:26548598 |
Gclc | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of GCLC mRNA more ... | CTD | PMID:32979393 more ... |
Gclc | Rat | perfluorooctanoic acid | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | perfluorooctanoic acid results in decreased expression of GCLC mRNA | CTD | PMID:23567314 and PMID:30547568 |
Gclc | Rat | perfluoroundecanoic acid | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | perfluoroundecanoic acid results in decreased expression of GCLC mRNA | CTD | PMID:23567314 |
Gclc | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GCLC mRNA | CTD | PMID:28659758 |
Gclc | Rat | phenethyl caffeate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | caffeic acid phenethyl ester inhibits the reaction [Bleomycin results in decreased expression of GCLC protein] | CTD | PMID:23570914 |
Gclc | Rat | phenethyl isothiocyanate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | phenethyl isothiocyanate results in increased expression of GCLC mRNA | CTD | PMID:20442190 |
Gclc | Rat | phenobarbital | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of GCLC mRNA | CTD | PMID:19270015 |
Gclc | Rat | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of GCLC mRNA | CTD | PMID:19162173 |
Gclc | Rat | phenol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Phenol results in increased expression of GCLC mRNA | CTD | PMID:26198647 |
Gclc | Rat | phenylmercury acetate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of GCLC mRNA | CTD | PMID:26272509 |
Gclc | Rat | phenylmercury acetate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GCLC mRNA | CTD | PMID:27188386 |
Gclc | Rat | phlorizin | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Phlorhizin results in decreased expression of GCLC mRNA | CTD | PMID:22538082 |
Gclc | Rat | phloroglucinol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Phloroglucinol results in increased expression of GCLC protein | CTD | PMID:20188716 |
Gclc | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Rosuvastatin Calcium] results in increased expression of GCLC mRNA | CTD | PMID:18154958 |
Gclc | Rat | phorbol 13-acetate 12-myristate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of GCLC mRNA | CTD | PMID:18154958 and PMID:26198647 |
Gclc | Rat | phorbol 13-acetate 12-myristate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of GCLC mRNA | CTD | PMID:17200146 |
Gclc | Rat | phosgene | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Phosgene affects the expression of GCLC mRNA | CTD | PMID:16300373 |
Gclc | Rat | piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
Gclc | Rat | pirinixic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | pirinixic acid results in increased expression of GCLC mRNA | CTD | PMID:17426115 |
Gclc | Rat | pirinixic acid | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of GCLC mRNA | CTD | PMID:18445702 |
Gclc | Rat | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of GCLC mRNA | CTD | PMID:15890375 and PMID:19162173 |
Gclc | Rat | Polpunonic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | maytenonic acid results in increased expression of GCLC mRNA | CTD | PMID:27751938 |
Gclc | Rat | Polpunonic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | maytenonic acid results in increased expression of GCLC mRNA | CTD | PMID:27751938 |
Gclc | Rat | potassium chloride | multiple interactions | EXP | | 6480464 | [Desoxycorticosterone Acetate co-treated with Sodium Chloride and Dietary co-treated with Potassium Chloride] results in decreased expression of GCLC mRNA | CTD | PMID:22228705 |
Gclc | Rat | potassium chromate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of GCLC mRNA] | CTD | PMID:14625279 |
Gclc | Rat | potassium dichromate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of GCLC mRNA] | CTD | PMID:14625279 |
Gclc | Rat | pravastatin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Pravastatin results in increased expression of GCLC mRNA | CTD | PMID:27225895 |
Gclc | Rat | pravastatin | decreases expression | EXP | | 6480464 | Pravastatin results in decreased expression of GCLC mRNA | CTD | PMID:27225895 |
Gclc | Rat | prazosin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Prazosin inhibits the reaction [Acetaminophen results in increased expression of GCLC mRNA] | CTD | PMID:18071297 |
Gclc | Rat | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of GCLC mRNA | CTD | PMID:19162173 |
Gclc | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of GCLC mRNA | CTD | PMID:28903501 |
Gclc | Rat | procyanidin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 2-(1 more ... | CTD | PMID:39117098 |
Gclc | Rat | progesterone | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Progesterone results in decreased expression of GCLC mRNA | CTD | PMID:22238285 |
Gclc | Rat | propacetamol | affects expression | ISO | Gclc (Mus musculus) | 6480464 | propacetamol affects the expression of GCLC protein | CTD | PMID:29574133 |
Gclc | Rat | propacetamol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | kaempferol affects the reaction [propacetamol affects the expression of GCLC protein] | CTD | PMID:29574133 |
Gclc | Rat | propan-2-ol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | 2-Propanol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | propanal | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of GCLC mRNA | CTD | PMID:26079696 |
Gclc | Rat | prostaglandin J2 | increases expression | EXP | | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GCLC mRNA and 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GCLC protein | CTD | PMID:18332871 |
Gclc | Rat | puerarin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC mRNA more ... | CTD | PMID:32763437 |
Gclc | Rat | puerarin | multiple interactions | EXP | | 6480464 | [1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC mRNA and [1-Methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC protein | CTD | PMID:32763437 |
Gclc | Rat | pyocyanine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Pyocyanine results in increased expression of GCLC mRNA | CTD | PMID:24015256 |
Gclc | Rat | pyocyanine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Pyocyanine results in increased localization of NFE2L2 protein] which results in increased expression of GCLC mRNA and trigonelline inhibits the reaction [Pyocyanine results in increased expression of GCLC mRNA] | CTD | PMID:24015256 |
Gclc | Rat | pyrazines | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Pyrazines analog results in increased expression of GCLC mRNA | CTD | PMID:25056784 |
Gclc | Rat | pyrethrins | decreases expression | EXP | | 6480464 | Pyrethrins results in decreased expression of GCLC protein | CTD | PMID:34896426 |
Gclc | Rat | Pyridostigmine bromide | multiple interactions | EXP | | 6480464 | [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GCLC mRNA | CTD | PMID:28659758 |
Gclc | Rat | pyrroloquinoline quinone | multiple interactions | EXP | | 6480464 | PQQ Cofactor inhibits the reaction [Rotenone results in decreased expression of GCLC mRNA] | CTD | PMID:26276080 |
Gclc | Rat | quercetin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Quercetin results in increased expression of GCLC mRNA and Quercetin results in increased expression of GCLC protein | CTD | PMID:11864778 more ... |
Gclc | Rat | quercetin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Quercetin results in increased expression of GCLC protein] | CTD | PMID:36584933 |
Gclc | Rat | quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of GCLC mRNA and Quercetin results in increased expression of GCLC protein | CTD | PMID:19798679 more ... |
Gclc | Rat | quercetin | multiple interactions | EXP | | 6480464 | [quercetin 3-O-glucuronide co-treated with 3-methylquercetin co-treated with Quercetin] results in increased expression of GCLC mRNA more ... | CTD | PMID:19798679 more ... |
Gclc | Rat | quercetin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [clivorine co-treated with Quercetin] results in increased expression of GCLC mRNA more ... | CTD | PMID:25881548 |
Gclc | Rat | quercetin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Quercetin results in increased expression of GCLC mRNA and Quercetin results in increased expression of GCLC protein | CTD | PMID:19183254 and PMID:36584933 |
Gclc | Rat | quercetin | affects expression | EXP | | 6480464 | Quercetin affects the expression of GCLC mRNA | CTD | PMID:18178720 |
Gclc | Rat | rac-lactic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | reactive oxygen species | decreases abundance | ISO | GCLC (Homo sapiens) | 6480464 | GCLC gene SNP results in decreased abundance of Reactive Oxygen Species | CTD | PMID:32715377 |
Gclc | Rat | reactive oxygen species | affects abundance | ISO | Gclc (Mus musculus) | 6480464 | GCLC protein affects the abundance of Reactive Oxygen Species | CTD | PMID:35123994 |
Gclc | Rat | reactive oxygen species | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Reactive Oxygen Species affects the expression of GCLC mRNA | CTD | PMID:25800948 |
Gclc | Rat | reactive oxygen species | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | CTD | PMID:22864849 |
Gclc | Rat | reactive oxygen species | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [[[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] which results in increased abundance of Glutathione and [[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein | CTD | PMID:21728338 |
Gclc | Rat | resorcinol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | resorcinol results in increased expression of GCLC mRNA | CTD | PMID:30806763 |
Gclc | Rat | resveratrol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:11909699 more ... |
Gclc | Rat | resveratrol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein affects the reaction [Resveratrol results in increased expression of GCLC protein] | CTD | PMID:36584933 |
Gclc | Rat | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA] and resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC protein] | CTD | PMID:21439372 |
Gclc | Rat | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:15882976 |
Gclc | Rat | resveratrol | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Resveratrol results in increased expression of GCLC mRNA and Resveratrol results in increased expression of GCLC protein | CTD | PMID:21520053 and PMID:36584933 |
Gclc | Rat | resveratrol | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Resveratrol results in increased expression of GCLC mRNA] more ... | CTD | PMID:11909699 more ... |
Gclc | Rat | rosuvastatin calcium | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Tetradecanoylphorbol Acetate co-treated with Rosuvastatin Calcium] results in increased expression of GCLC mRNA | CTD | PMID:18154958 |
Gclc | Rat | rosuvastatin calcium | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Rosuvastatin Calcium results in increased expression of GCLC mRNA | CTD | PMID:18154958 |
Gclc | Rat | rotenone | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Rotenone results in increased expression of GCLC mRNA | CTD | PMID:17657281 |
Gclc | Rat | rotenone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Rotenone results in increased expression of GCLC mRNA | CTD | PMID:36586010 |
Gclc | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of GCLC mRNA | CTD | PMID:26276080 |
Gclc | Rat | rotenone | multiple interactions | EXP | | 6480464 | PQQ Cofactor inhibits the reaction [Rotenone results in decreased expression of GCLC mRNA] | CTD | PMID:26276080 |
Gclc | Rat | rottlerin | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | rottlerin inhibits the reaction [[3-methylquercetin results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein] and rottlerin inhibits the reaction [Plant Extracts results in increased expression of GCLC protein] | CTD | PMID:24211276 and PMID:30626086 |
Gclc | Rat | rottlerin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLC mRNA]] more ... | CTD | PMID:25895139 more ... |
Gclc | Rat | rottlerin | multiple interactions | EXP | | 6480464 | rottlerin inhibits the reaction [naringin results in increased expression of GCLC protein] | CTD | PMID:25773745 |
Gclc | Rat | S-adenosyl-L-methioninate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | S-Adenosylmethionine inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA] and S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA]] | CTD | PMID:20146260 |
Gclc | Rat | S-adenosyl-L-methionine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | S-Adenosylmethionine inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA] and S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA]] | CTD | PMID:20146260 |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases activity | ISO | Gclc (Mus musculus) | 6480464 | Buthionine Sulfoximine results in decreased activity of GCLC protein | CTD | PMID:15707499 and PMID:7955076 |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Buthionine Sulfoximine results in decreased expression of GCLC protein | CTD | PMID:35298964 |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | EXP | | 6480464 | Buthionine Sulfoximine results in increased expression of GCLC mRNA | CTD | PMID:10978506 and PMID:23585199 |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Buthionine Sulfoximine inhibits the reaction [[Lithocholic Acid results in increased expression of GCLC protein] which results in increased abundance of Glutathione] more ... | CTD | PMID:17724089 more ... |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases activity | EXP | | 6480464 | Buthionine Sulfoximine results in decreased activity of GCLC protein | CTD | PMID:12433058 |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | [Buthionine Sulfoximine co-treated with Carmustine] results in decreased activity of GCLC protein more ... | CTD | PMID:12967637 more ... |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Buthionine Sulfoximine results in increased expression of GCLC mRNA | CTD | PMID:17980396 more ... |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | increases activity | ISO | Gclc (Mus musculus) | 6480464 | Buthionine Sulfoximine results in increased activity of GCLC protein | CTD | PMID:10915739 |
Gclc | Rat | S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Buthionine Sulfoximine results in decreased activity of GCLC protein] inhibits the reaction [indenoindole results in increased abundance of Glutathione] more ... | CTD | PMID:10900227 more ... |
Gclc | Rat | SB 203580 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [Plant Extracts results in increased expression of GCLC protein] and SB 203580 inhibits the reaction [sodium arsenite results in increased expression of GCLC protein] | CTD | PMID:25201354 and PMID:30626086 |
Gclc | Rat | SB 203580 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | SB 203580 inhibits the reaction [2' more ... | CTD | PMID:31029725 |
Gclc | Rat | SB 431542 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:34480604 |
Gclc | Rat | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA | CTD | PMID:11444866 |
Gclc | Rat | selenocystine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 mutant form inhibits the reaction [selenocystine results in increased expression of GCLC mRNA] | CTD | PMID:22807314 |
Gclc | Rat | selenocystine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | selenocystine results in increased expression of GCLC mRNA | CTD | PMID:22807314 |
Gclc | Rat | selenomethionine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Selenomethionine results in increased expression of GCLC mRNA | CTD | PMID:22807314 |
Gclc | Rat | sevoflurane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of GCLC protein] | CTD | PMID:35350913 |
Gclc | Rat | sevoflurane | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Sevoflurane results in decreased expression of GCLC protein | CTD | PMID:35350913 |
Gclc | Rat | silicon atom | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Thioctic Acid inhibits the reaction [Silicon results in decreased expression of GCLC protein] | CTD | PMID:34252510 |
Gclc | Rat | silicon atom | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Silicon results in decreased expression of GCLC protein | CTD | PMID:34252510 |
Gclc | Rat | silicon dioxide | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of GCLC mRNA | CTD | PMID:25895662 |
Gclc | Rat | silicon dioxide | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of GCLC mRNA | CTD | PMID:23221170 |
Gclc | Rat | silver atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLC mRNA] | CTD | PMID:22546375 |
Gclc | Rat | silver atom | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:27131904 |
Gclc | Rat | silver atom | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22036727 more ... |
Gclc | Rat | silver(0) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLC mRNA] | CTD | PMID:22546375 |
Gclc | Rat | silver(0) | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:27131904 |
Gclc | Rat | silver(0) | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22036727 more ... |
Gclc | Rat | silver(1+) nitrate | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Silver Nitrate results in decreased expression of GCLC mRNA | CTD | PMID:19733233 |
Gclc | Rat | SL-327 | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | SL 327 inhibits the reaction [Melatonin inhibits the reaction [KL mutant form results in decreased expression of GCLC mRNA]] | CTD | PMID:25550330 |
Gclc | Rat | sodium arsenate | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GCLC mRNA and [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of GCLC protein | CTD | PMID:32525701 and PMID:33434570 |
Gclc | Rat | sodium arsenate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | sodium arsenate results in increased expression of GCLC mRNA | CTD | PMID:12727804 |
Gclc | Rat | sodium arsenite | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GCLC mRNA and sodium arsenite results in increased expression of GCLC protein | CTD | PMID:12441363 more ... |
Gclc | Rat | sodium arsenite | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of GCLC mRNA | CTD | PMID:34032870 more ... |
Gclc | Rat | sodium arsenite | affects methylation | ISO | GCLC (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of GCLC gene | CTD | PMID:28589171 |
Gclc | Rat | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of GCLC mRNA and sodium arsenite results in increased expression of GCLC protein | CTD | PMID:12210719 and PMID:21465251 |
Gclc | Rat | sodium arsenite | affects expression | EXP | | 6480464 | sodium arsenite affects the expression of GCLC mRNA | CTD | PMID:25625412 |
Gclc | Rat | sodium arsenite | increases expression | ISO | Gclc (Mus musculus) | 6480464 | sodium arsenite results in increased expression of GCLC mRNA and sodium arsenite results in increased expression of GCLC protein | CTD | PMID:16014739 more ... |
Gclc | Rat | sodium arsenite | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [GCLM co-treated with GCLC] inhibits the reaction [sodium arsenite results in increased activity of and results in increased cleavage of CASP3 protein] more ... | CTD | PMID:20006689 more ... |
Gclc | Rat | sodium arsenite | increases activity | ISO | GCLC (Homo sapiens) | 6480464 | sodium arsenite results in increased activity of GCLC protein | CTD | PMID:12441363 |
Gclc | Rat | sodium arsenite | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [sodium arsenite results in increased expression of GCLC protein] more ... | CTD | PMID:20805060 more ... |
Gclc | Rat | sodium cholate | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Cholesterol more ... | CTD | PMID:27394961 |
Gclc | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of GCLC mRNA | CTD | PMID:22561333 |
Gclc | Rat | sodium dichromate | increases expression | ISO | Gclc (Mus musculus) | 6480464 | sodium bichromate results in increased expression of GCLC mRNA | CTD | PMID:22155349 |
Gclc | Rat | sodium dichromate | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | sodium bichromate results in decreased expression of GCLC mRNA | CTD | PMID:22155349 |
Gclc | Rat | sodium dodecyl sulfate | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Sodium Dodecyl Sulfate results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | sodium fluoride | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of GCLC mRNA | CTD | PMID:27862939 |
Gclc | Rat | spironolactone | multiple interactions | EXP | | 6480464 | Spironolactone inhibits the reaction [Aldosterone results in increased expression of GCLC protein] | CTD | PMID:24512358 and PMID:25204689 |
Gclc | Rat | staurosporine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Staurosporine promotes the reaction [MYC protein binds to GCLC promoter] | CTD | PMID:17628013 |
Gclc | Rat | stavudine | increases expression | EXP | | 6480464 | Stavudine results in increased expression of GCLC mRNA | CTD | PMID:18299183 |
Gclc | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA more ... | CTD | PMID:21439372 and PMID:33639173 |
Gclc | Rat | streptozocin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Dietary Fats co-treated with Streptozocin] results in decreased expression of GCLC mRNA and ginsenoside Rh4 inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of GCLC mRNA] | CTD | PMID:33359794 |
Gclc | Rat | streptozocin | decreases expression | EXP | | 6480464 | Streptozocin results in decreased expression of GCLC mRNA and Streptozocin results in decreased expression of GCLC protein | CTD | PMID:33639173 |
Gclc | Rat | styrene | increases activity | ISO | Gclc (Mus musculus) | 6480464 | Styrene results in increased activity of GCLC protein | CTD | PMID:16971035 |
Gclc | Rat | succimer | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLC mRNA | CTD | PMID:26378955 |
Gclc | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of GCLC mRNA | CTD | PMID:30047161 |
Gclc | Rat | sulforaphane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [sulforaphane co-treated with Acetaminophen] results in increased expression of GCLC mRNA more ... | CTD | PMID:17942926 more ... |
Gclc | Rat | sulforaphane | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of GCLC mRNA | CTD | PMID:35724838 |
Gclc | Rat | sulforaphane | decreases methylation | ISO | GCLC (Homo sapiens) | 6480464 | sulforaphane results in decreased methylation of GCLC gene | CTD | PMID:31838189 |
Gclc | Rat | sulforaphane | increases expression | ISO | Gclc (Mus musculus) | 6480464 | sulforaphane results in increased expression of GCLC mRNA and sulforaphane results in increased expression of GCLC protein | CTD | PMID:17942926 more ... |
Gclc | Rat | sulforaphane | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | sulforaphane results in increased expression of GCLC mRNA and sulforaphane results in increased expression of GCLC protein | CTD | PMID:20442190 more ... |
Gclc | Rat | sulforaphane | increases expression | EXP | | 6480464 | sulforaphane results in increased expression of GCLC mRNA and sulforaphane results in increased expression of GCLC protein | CTD | PMID:21871945 and PMID:22558124 |
Gclc | Rat | sulforaphane | multiple interactions | EXP | | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine inhibits the reaction [sulforaphane results in increased expression of GCLC mRNA] | CTD | PMID:21871945 |
Gclc | Rat | sulforaphane | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | alpha-methylepinine promotes the reaction [sulforaphane results in increased expression of GCLC mRNA] more ... | CTD | PMID:21871945 more ... |
Gclc | Rat | sulindac | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [Sulindac results in increased expression of GCLC protein] | CTD | PMID:11820781 |
Gclc | Rat | sulindac | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Sulindac results in increased expression of GCLC protein | CTD | PMID:11820781 |
Gclc | Rat | sulindac | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | Sulindac affects the expression of GCLC mRNA | CTD | PMID:15946948 |
Gclc | Rat | sunitinib | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Sunitinib results in increased expression of GCLC mRNA | CTD | PMID:31533062 |
Gclc | Rat | suprofen | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Suprofen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
Gclc | Rat | T-2 toxin | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | T-2 Toxin results in decreased expression of GCLC mRNA | CTD | PMID:20854872 |
Gclc | Rat | T-2 toxin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | T-2 Toxin results in increased expression of GCLC mRNA | CTD | PMID:33508416 |
Gclc | Rat | tamoxifen | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Tamoxifen affects the expression of GCLC mRNA | CTD | PMID:20937368 |
Gclc | Rat | tectorigenin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [tectorigenin co-treated with 1-Naphthylisothiocyanate] results in increased expression of GCLC protein and tectorigenin inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of GCLC mRNA] | CTD | PMID:37348807 |
Gclc | Rat | tert-butyl hydroperoxide | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Linoleic Acids and Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:17092368 |
Gclc | Rat | tert-butyl hydroperoxide | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | tert-Butylhydroperoxide results in decreased expression of GCLC mRNA | CTD | PMID:30547568 |
Gclc | Rat | tert-butyl hydroperoxide | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of GCLC mRNA | CTD | PMID:23410634 and PMID:27509014 |
Gclc | Rat | tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide more ... | CTD | PMID:22864849 |
Gclc | Rat | tert-butyl hydroperoxide | decreases response to substance | EXP | | 6480464 | GCLC protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:12425961 |
Gclc | Rat | tetrachloromethane | affects expression | ISO | Gclc (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of GCLC mRNA | CTD | PMID:17484886 |
Gclc | Rat | tetrachloromethane | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Carbon Tetrachloride results in increased expression of GCLC mRNA | CTD | PMID:32234387 |
Gclc | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of GCLC mRNA | CTD | PMID:31150632 |
Gclc | Rat | tetrachloromethane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | AK-1 compound promotes the reaction [Carbon Tetrachloride results in increased expression of GCLC mRNA] more ... | CTD | PMID:21725986 more ... |
Gclc | Rat | tetrachloromethane | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of GCLC mRNA and Carbon Tetrachloride results in decreased expression of GCLC protein | CTD | PMID:27477297 more ... |
Gclc | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | diallyl disulfide inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA] and schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of GCLC mRNA] | CTD | PMID:24293383 and PMID:31150632 |
Gclc | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of GCLC mRNA | CTD | PMID:24293383 |
Gclc | Rat | tetrachloromethane | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of GCLC mRNA and Carbon Tetrachloride results in increased expression of GCLC protein | CTD | PMID:10915739 more ... |
Gclc | Rat | tetrachloromethane | decreases activity | ISO | Gclc (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased activity of GCLC protein | CTD | PMID:10915739 |
Gclc | Rat | tetramethylpyrazine | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | tetramethylpyrazine analog results in increased expression of GCLC mRNA and tetramethylpyrazine analog results in increased expression of GCLC protein | CTD | PMID:25056784 |
Gclc | Rat | tetramethylpyrazine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 protein promotes the reaction [tetramethylpyrazine inhibits the reaction [Carbon Tetrachloride results in decreased expression of GCLC mRNA]] more ... | CTD | PMID:27477297 |
Gclc | Rat | thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of GCLC protein | CTD | PMID:35544339 |
Gclc | Rat | thiabendazole | increases activity | ISO | Gclc (Mus musculus) | 6480464 | Thiabendazole results in increased activity of GCLC protein | CTD | PMID:11019651 |
Gclc | Rat | thiabendazole | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Thiabendazole co-treated with Buthionine Sulfoximine] results in increased activity of GCLC protein | CTD | PMID:11019651 |
Gclc | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GCLC mRNA and Thioacetamide results in increased expression of GCLC protein | CTD | PMID:10486302 more ... |
Gclc | Rat | thioacetamide | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of GCLC mRNA | CTD | PMID:28943392 |
Gclc | Rat | thiram | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Thiram results in decreased expression of GCLC mRNA | CTD | PMID:38568856 |
Gclc | Rat | titanium dioxide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | titanium dioxide results in increased expression of GCLC mRNA | CTD | PMID:23557971 |
Gclc | Rat | titanium dioxide | increases methylation | ISO | Gclc (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of GCLC gene | CTD | PMID:35295148 |
Gclc | Rat | titanium dioxide | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of GCLC protein | CTD | PMID:28780322 |
Gclc | Rat | titanium dioxide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLC mRNA and Grape Seed Proanthocyanidins inhibits the reaction [titanium dioxide results in decreased expression of GCLC protein] | CTD | PMID:28780322 and PMID:29950665 |
Gclc | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of GCLC mRNA | CTD | PMID:25729387 |
Gclc | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GCLC mRNA and [Topotecan co-treated with oxaliplatin] results in decreased expression of GCLC mRNA | CTD | PMID:25729387 |
Gclc | Rat | trans-isoeugenol | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | isoeugenol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
Gclc | Rat | triacsin C | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | triacsin C results in increased expression of GCLC mRNA | CTD | PMID:16704987 |
Gclc | Rat | tributylstannane | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | PRKCD gene mutant form promotes the reaction [tributyltin results in increased expression of GCLC mRNA] | CTD | PMID:25895139 |
Gclc | Rat | Trichloroacetonitrile | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | trichloroacetonitrile results in increased expression of GCLC mRNA | CTD | PMID:35842135 |
Gclc | Rat | trichostatin A | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | trichostatin A results in increased expression of GCLC mRNA | CTD | PMID:21319187 |
Gclc | Rat | trichostatin A | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [Fenretinide co-treated with trichostatin A] results in increased expression of GCLC mRNA | CTD | PMID:21319187 |
Gclc | Rat | trimethyltin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | trimethyltin results in increased expression of GCLC mRNA | CTD | PMID:25895139 |
Gclc | Rat | trimethyltin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin promotes the reaction [trimethyltin results in increased expression of GCLC mRNA]] and rottlerin promotes the reaction [trimethyltin results in increased expression of GCLC mRNA] | CTD | PMID:25895139 |
Gclc | Rat | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of GCLC mRNA | CTD | PMID:30589522 |
Gclc | Rat | triphenyl phosphate | affects expression | ISO | GCLC (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of GCLC mRNA | CTD | PMID:37042841 |
Gclc | Rat | Triptolide | multiple interactions | EXP | | 6480464 | NFE2L2 protein inhibits the reaction [triptolide results in decreased expression of GCLC protein] | CTD | PMID:25169008 |
Gclc | Rat | Triptolide | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | triptolide results in decreased expression of GCLC protein | CTD | PMID:25169008 |
Gclc | Rat | Triptolide | decreases expression | EXP | | 6480464 | triptolide results in decreased expression of GCLC protein | CTD | PMID:25169008 |
Gclc | Rat | troglitazone | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | troglitazone results in increased expression of GCLC mRNA | CTD | PMID:19140230 |
Gclc | Rat | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | trovafloxacin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of GCLC mRNA | CTD | PMID:18930950 |
Gclc | Rat | tunicamycin | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GCLC mRNA] | CTD | PMID:22959925 |
Gclc | Rat | tunicamycin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of GCLC mRNA | CTD | PMID:36586010 |
Gclc | Rat | tunicamycin | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Tunicamycin results in increased expression of GCLC mRNA | CTD | PMID:22959925 |
Gclc | Rat | tyloxapol | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | tyloxapol results in decreased expression of GCLC protein | CTD | PMID:36905866 |
Gclc | Rat | tyloxapol | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Escin inhibits the reaction [tyloxapol results in decreased expression of GCLC protein] and Fenofibrate inhibits the reaction [tyloxapol results in decreased expression of GCLC protein] | CTD | PMID:36905866 |
Gclc | Rat | tyrphostin AG 1478 | multiple interactions | EXP | | 6480464 | Doxorubicin promotes the reaction [RTKI cpd results in decreased expression of GCLC protein] | CTD | PMID:18371937 |
Gclc | Rat | tyrphostin AG 1478 | decreases expression | EXP | | 6480464 | RTKI cpd results in decreased expression of GCLC protein | CTD | PMID:18371937 |
Gclc | Rat | urethane | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Urethane results in increased expression of GCLC mRNA | CTD | PMID:28818685 |
Gclc | Rat | ursodeoxycholic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased expression of GCLC mRNA] more ... | CTD | PMID:19073151 and PMID:20146260 |
Gclc | Rat | ursodeoxycholic acid | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Ursodeoxycholic Acid results in increased expression of GCLC mRNA and Ursodeoxycholic Acid results in increased expression of GCLC protein | CTD | PMID:18687751 |
Gclc | Rat | ursodeoxycholic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Ursodeoxycholic Acid results in increased expression of GCLC mRNA | CTD | PMID:19073151 |
Gclc | Rat | ursodeoxycholic acid | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of GCLC mRNA] | CTD | PMID:18687751 |
Gclc | Rat | usnic acid | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | NFE2L2 protein promotes the reaction [usnic acid results in increased expression of GCLC protein] | CTD | PMID:27369375 |
Gclc | Rat | usnic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | usnic acid results in increased expression of GCLC mRNA and usnic acid results in increased expression of GCLC protein | CTD | PMID:27369375 |
Gclc | Rat | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of GCLC mRNA | CTD | PMID:24136188 |
Gclc | Rat | valproic acid | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of GCLC mRNA | CTD | PMID:25716160 |
Gclc | Rat | vanillin | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | vanillin results in increased expression of GCLC mRNA | CTD | PMID:17178418 |
Gclc | Rat | verteporfin | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Verteporfin results in decreased expression of GCLC protein | CTD | PMID:37832483 |
Gclc | Rat | vincristine | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine | CTD | PMID:10900222 |
Gclc | Rat | vitamin E | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | Vitamin E inhibits the reaction [Alcohols results in increased expression of GCLC mRNA] | CTD | PMID:18814483 |
Gclc | Rat | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA and Vitamin E affects the reaction [[REL binds to GCLC promoter] which affects the expression of GCLC mRNA] | CTD | PMID:11444866 and PMID:16298738 |
Gclc | Rat | vitamin E | affects expression | EXP | | 6480464 | Vitamin E affects the expression of GCLC mRNA and Vitamin E affects the expression of GCLC protein | CTD | PMID:16298738 |
Gclc | Rat | water | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GCLC mRNA | CTD | PMID:29335169 |
Gclc | Rat | withaferin A | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | withaferin A inhibits the reaction [Ethanol results in increased expression of GCLC mRNA] | CTD | PMID:34995708 |
Gclc | Rat | XAV939 | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of GCLC mRNA | CTD | PMID:34480604 |
Gclc | Rat | yohimbine | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | [Caffeine co-treated with coclaurine co-treated with aegeline co-treated with higenamine co-treated with Yohimbine co-treated with Hydrolyzable Tannins] results in increased expression of GCLC mRNA | CTD | PMID:28843594 |
Gclc | Rat | zinc atom | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | acetyl-valyl-isoleucyl-aspartyl-aldehyde inhibits the reaction [Zinc deficiency results in increased cleavage of GCLC protein] more ... | CTD | PMID:23377617 |
Gclc | Rat | zinc atom | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of GCLC mRNA | CTD | PMID:23377617 |
Gclc | Rat | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of GCLC mRNA and Zinc deficiency results in decreased expression of GCLC protein | CTD | PMID:23377617 |
Gclc | Rat | zinc dichloride | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLC mRNA] | CTD | PMID:18385089 |
Gclc | Rat | zinc dichloride | increases expression | ISO | GCLC (Homo sapiens) | 6480464 | zinc chloride results in increased expression of GCLC mRNA | CTD | PMID:33645215 |
Gclc | Rat | zinc oxide | multiple interactions | ISO | Gclc (Mus musculus) | 6480464 | 1-(2-cyano-3 more ... | CTD | PMID:30500950 more ... |
Gclc | Rat | zinc oxide | increases expression | ISO | Gclc (Mus musculus) | 6480464 | Zinc Oxide analog results in increased expression of GCLC protein | CTD | PMID:35247504 |
Gclc | Rat | zinc oxide | decreases expression | ISO | Gclc (Mus musculus) | 6480464 | Zinc Oxide analog results in decreased expression of GCLC mRNA | CTD | PMID:36100149 |
Gclc | Rat | zinc(0) | multiple interactions | ISO | GCLC (Homo sapiens) | 6480464 | acetyl-valyl-isoleucyl-aspartyl-aldehyde inhibits the reaction [Zinc deficiency results in increased cleavage of GCLC protein] more ... | CTD | PMID:23377617 |
Gclc | Rat | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of GCLC mRNA and Zinc deficiency results in decreased expression of GCLC protein | CTD | PMID:23377617 |
Gclc | Rat | zinc(0) | decreases expression | ISO | GCLC (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of GCLC mRNA | CTD | PMID:23377617 |